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Abstract 
There is a small group of natural products which possess a 3-acyl-4-hydroxypyridin-2-
one core. It has been our intention over the course of this PhD to synthesis the 
acylpyridone core in masked form and then to elaborate from this to a specific natural 
product. 
This thesis introduces these natural products and surveys the synthetic work on this class 
of metabolites. It next describes our strategy, which involved masking the 4-hydroxy and 
3-acyl functions jointly as an isoxazole to reduce the polarity of these molecules and 
hence make handling and purification easier. The isoxazole is made via a 1,3-dipolar 
cycloaddition of an in situ generated nitrile oxide and a pyrrolidine enamine. Our 
realization of this approach using 2,3-diaminopropionic' acid via its aldehyde as the 
source of nitrile oxide, and a p-ketoester as the source of the enamine, is described. 
Manipulation of the initially-formed isoxazole to generate an isoxazolopyridone building 
block is reported. Elaboration of. the isoxazolopyridone at the C-3 substituent by anion 
generation and aldol-type chemistry, and at the C-7 position by iodination and Pd-
mediated Suzuki coupling has been achieved. This methodology has been utilized in 
making progress towards synthesis of the natural product tenellin. 
The weak N-O bond of the isoxazole has been easily cleaved in the last step of the 
synthesis, followed by diazotization to reveal the 3-acyl-4-hydroxy-pyridin-2-one core. 
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Chapter 1 Introduction 
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1.1 The 3-Acyl-4-hydroxypyridin-2-ones 
There is a group of naturally occurring compounds that contain the 3-acyl-4-
hydroxypyridin-2-one unit 1. The 4-hydroxy substituent exists fully enolised, the R2 unit 
in most of these natural products contains a 4-hydroxyphenyl substituent, RI is either a 
hydroxy, hydrogen or methyl unit and the structure of R3 in most cases is a conjugated 
alkene system. At present there are over 20 of these compounds known natura1ly, and 
new examples are still being found, e.g. militarinone A 13 was first isolated in 2002.1 
OH 0 
1 
6 
1.2 Isolation and Biological activity 
Tenellin 2 and bassianin 3 are two of the most common and frequently reported of this 
class of natural products. Cultures of the insect pathogenic fungi Beauveria bassiana 
(Bals.) Vuill. and Beauveria tenella (Delacroix) Siem. tend to develop a yellow colour 
due to the fonnation of a mixture of related pigments.2 Two of these pigments were 
isolated, tenellin 2 and bassianin 3, and their structures confinned by NMR and mass 
spectroscopy.3 I1icicolin H 4 is an antifungal antibiotic isolated from the mycelium of the 
imperfect fungus Cylindrocladium ilicicola.4 The structure is similar to tenellin and 
bassianin except for the presence of a bicyclic decalin system that is relatively novel in a 
fungal metabolite derived from a linear polyketide pathway. 
HO 
OH o 
N 0 
I n = 1 TenelIin 2 
OH n = 2 Bassianin 3 
HO ~ l OH 0 
~ ~ 
, i 
N 0 
~ 
H H 
ilicicolin H 4 
7 
There is a group of narrow spectrum antibiotics which contain the 3-acyl-4-
hydroxypyridin-2-one unit but lack the 4-hydroxyphenyl substituent at the C-5 position.5 
There are at least six known members with aurodox 5 and efrotomycin 6 being the most 
well known. The other members of this class have similar and equally complex 
structures. Aurodox 5 was isolated in 1972 from Streptomyces goldiniensis by Maehr 
et. al. 6 and the same group completed structural elucidation in 1973.7 Efrotomycin was 
isolated from Streptomyces lactamdurans in 19768 by a Merck, Sharp & Dohme group 
and the structure also elucidated by a group from this company.9 These antibiotics are 
primarily active against a small number of Gram-positive bacteria. The mode of action 
has been studied using kirromycin 7 and involves inhibition of protein synthesis. 
Interaction with the elongation factor Tu in prokaryotic cells was demonstrated and a 
similar mode of action is probable for the other members of this group, and hence the 
collective term elfamycins has been proposed to emphasise elongation factor 
involvement. 
OH 0 H~ pH 0 OH ~ ! ~ I ., ~ ~ ! ~ ~ ~ N 
H ) OM. 
N !, 
RI "" CH3• Rl = H Aurodox S 
HO CC..., ...,CO OH 
R1=CH3.R2= OC..., Efrotomycin 6 
CH, CH, 
RI = R2 = H Kirromycin 7 
An antifungal metaboIite of Trichoderma harzianum known as harzianopyridone 8 also 
possesses the same enoIised tricarbonyl moiety and as yet is the only known metaboIite 
from ~is species that does so.IO The structure was determined by IH NMR spectroscopy, 
8 
# 
X-ray and mass spectrometry techniques and unusually possesses methoxy groups at the 
C-S & C-6 positions making it the only natural product of this type to do so. 
OH 0 
MeO 
MeO N o 
I 
H 
Harzianopyridone 8 
In 1993 Fujimoto et al. whilst conducting a screening programme on the biologically 
active components of fungi found that an acetone extract of Neosartorya flscheri Var. 
Fischeri caused tremors and lethal peritonitis in mice.11 The toxic component which 
caused peritonitis was isolated from the fungus and named as fischerin 9. After analysis 
of the spectral data the structure of fischerin 9 was deduced to be as shown. 
HO 
OH 0 
OH H 
~ H\\"'\··· 
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~ 
I CH, 
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Fischerin 9 
Apiosporamide 10 which possesses a similar structure to fischerin 9 was isolated in 1994 
by Alfatafta and Gloer from the coprophilous fungi Apiospora Montagnei during an 
investigation into antifungal agents.12 Apiosporamide 10 showed activity against another 
9 
coprophilous fungus Ascobulus forforaceus causing a 58% reduction in radial growth rate 
relative to controls at 200 J.lg/disk. Apiosporamide 10 also showed zones of inhibition 
against Bacillus subtilis and Staphylococcus aureus. 
H 
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Apiosporamide 10 
The more recently discovered of this group of compounds include pyridovericin 11 and 
pyridomacrolidin 12, which were isolated in 1998 by Nakagawa and co-workers from B. 
bassiana 13 Both contain an E-diene fragment like teneIlin, with the inclusion of a 
hydroxy grouping. Pyridomacrolidin also contains a complex ten-membered ring lactone 
extending from the nitrogen of the pyridone ring. The biological activity of 11 and 12 
has been shown to include the inhibition of protein tyrosine kinase activity at 
concentrations of 100 J.lg/mL. PTK inhibitors are potential drugs against a variety of 
proliferative and inflanunatory diseases.14 
10 
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OH 
OH 
In 200 I Sclunidt et al. isolated the first compound in a small series known as the 
militarinones. Militarinone A 13 was isolated by bioassay-guided fractionation from the 
entomogenous fungus Paecilomyces militaris. The structure of 13 was confirmed by 
extensive spectroscopic analysis and contains a previously unreported side chain and a 
eis-(I,4-dihydroxycyclohexyl) moiety which has yet to be encountered in other microbial 
metabolites. Various concentrations of militarinone A 13 were evaluated for their 
potential to stimulate neuronal differentiation of PC-12 cells as the mycelial extract of a 
P. militaris strain displayed neuritogenic activity on PC-12 cells at 100 llg/mL. 
Compounds which respond to PC-12 cells have the potential to mimic neurotrophic 
factors (such as nerve growth factor) and thus may be of potential use against a number 
of neurodegenerative disorders including Alzheimer's disease. Whereas 25 ng/ml of the 
positive control nerve growth factor (NGF) induced pronounced neurite sprouting after 
11 
10 h hours, the effects of 13 reached a maximum after 24 h. At 33 !JM and 10 !JM 
concentrations 13 induced pronounced spikes in approximately 80 and 70% of cell 
aggregates respectively, whilst showing no cytoxicity in PC-12 cells at concentrations up 
to 100!JM. 
OH 0 
N 0 
I 
OH Militarinone A 13 
In 2003 the same authors investigated a P. militaris strain and TLC analysis revealed the 
presence of several minor pigments. IS The report describes the isolation and structure 
elucidation of three novel alkaloid pigments militarinones B, C & D (14-16). 
Militarinones B 14 and C 15 bear a conjugated side chain at C-7 and hence belong to a 
small group of compounds known as the polyenoyltetramic acids.16 Militarinone D 
contains the 4-hydroxyphenyl group at C-S which is present in many of the 3-acyl-4-
hydroxypyrldin-2-one natural products. Militarinones B, C and D were tested for their 
neuritogenic properties but showed very low activity. 
o OH 
HO o 
12 
R = OH MiJitarinone B 14 
R = H MiJitarinone C 15 
HO 
OH o 
Militarinone 0 16 
Farinosones A-C (17-19) were isolated in 2004 from the entomogenous deuteromycete 
Paecilomyces farinosus and their structures determined by various spectroscopic means 
including extensive NMR spectroscopic studies.t' Farinosone A 17 and Farinosone C 19 
induced a change in cell morphology and neurite outgrowth in PC-12 cells when tested at 
concentrations of20 and 50 IlM. Farinosone B 18 was not active and no cytotoxicity was 
observed for compounds 17-19. 
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1.3 Biosynthesis 
The biosyntheses of tenellin 2 and ilicicolin H 4 have been the subject of much research, 
and it has been presumed that the biosynthetic origin of these products is descended from 
a polyketide and an aromatic amino acid pathway. In 1974 it was suggested that tenellin 
2 was derived from acetate, phenylalanine and methionine18 and consequently Leete et al. 
carried out a feeding experiment with [l,3-l3C2]-phenylalanine to see if an intramolecular 
rearrangement of the phenylalanine side chain occurs during biosynthesis (Scheme 1).19 
The resultant l3C NMR spectra showed coupling between C-4 and C-5 of Tenellin 2, 
which is indeed suggestive of an intramolecular rearrangement of phenylalanine. 
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Scheme 1. Suggested biosynthesis of tenellin 2 by Leete et al. 
In some further work by Wright et at. on tenellin biosynthesis they have reported the 
efficient incorporation of L-[1 )4Cj-phenylalanine but poor incorporation of L-[U)4Cj-
tyrosine into the metabolite, thus reinforcing the conclusion that L-phenylalanine and not 
another possible precursor L-tyrosine is responsible for the 4-hydroxyphenyl substituent 
and C-4 to C-6 oftenellin.2o These authors proposed the process shown in Scheme 2. L-
Phenylalanine combines with the polyketide by analogy to the known biosynthesis of 
acyltetramic acids in fungi to form the tetramic acid 20. Oxidation at the 4-phenyl 
position would generate a quinoid intermediate which would enable ring expansion to 
yield the six membered moiety. This conjecture would satisfy the labelling pattern found 
from incorporation of [1,3-I3C2]-phenylalanine. 
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Scheme 2. Proposed route for the biosynthesis of teneIlin 2 by Wright et al. 
16 
The biosynthesis of ilicicolin H 4 has also been investigated using J3C-Iabelled precursors 
and J3C NMR spectroscopy?l [l_J3C]-, [2}3C]- and [1,2-J3C]- Labelled sodium acetates 
as well as L-[CH3}3C]-methionine and L_U_(14C)_, DL-[lsN]-labelled phenylalanine 
were fed to cultures of the producing organism Cylindrocladium ilicicola. The J3C_ 
acetate labelling results are consistent with a biosynthetic pathway that utilizes a 
polyketide precursor derived from eight intact acetate units with methylation at C-12 and 
C-16. The octaketide unit can then cyclise by standard aldol processes (Scheme 3) 
between C-S and C-9 and also between C-IO and C-IS. 
This produces an intermediate bicycle, which the authors presume interacts with 
phenylalanine to produce a tetramic acid intermediate. The same hypothesis used for 
tenellin biosynthesis is then adopted here with ring expansion facilitated via an electron 
deficient centre a to the tetramic acid to yield the six membered pyridone unit. 
17 
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Scheme 3. Proposed biosynthesis of iIicicolin H 4 by Tanabe & Drano. 
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In order to test this accepted hypothesis Moore et al. synthesised via a biomimetic 
strategy tetramic acids 21 and 22 labelled with 13C and 2H isotopes.22 13C labelled 
compound 21 was supplemented into flasks growing B. bassiana but, after HPLC 
purification there was no evidence of any isotope enrichment at C-4 after 13C NMR 
spectroscopic analysis. The experiment was repeated with 22, however after 2H NMR 
analysis there was no evidence of isotopic enrichment in the aryl hydrogens. An attempt 
was then made to try and fmd tetramic acid 21 in the fungal extract but this was abortive; 
the group then concluded that there was no evidence for the presence of 21 as a minor 
metabolite in the B. bassiana culture. 
These results led the group to re-examine the possible role of tyrosine in tenellin 2 
biosynthesis using [3-13C]-labelled amino acid. Analysis of the resultant tenellin 2 by 13C 
NMR spectroscopy revealed carbon-13 enrichment at C-5 of tenellin 2. A further 
experiment was conducted repeating the incorporation of DL-[l-13C]-phenylalanine, this 
led as shown by 13C NMR spectroscopy to a carbon-13 enrichment corresponding to C-4 
of tenellin 2. In summary both phenylalanine and tyrosine are expeditiously incorporated 
into tenellin. 
D 
HO 
D 
HO 
~D 
D ~ 
D 
o 
22 
19 
Moore et al. proposed there is a phenylalanine hydroxylase enzyme (P AH) functioning in 
B.bassiana, which converts phenylalanine into tyrosine (Scheme 4). This proposal is 
consistent with the inability of 21 to become incorporated into tenellin. The phenolic 
hydroxyl originates from tyrosine and not from a later stage modification of the aryl ring. 
0 
~ 0 
# 
\ B.bassiana PAH 0 0 
~ 0 ~ 0 
# ~ # "'NH3 HO HO DL-[3-13C]-tyrosine ! via L-[\ )3C]-tyrosine B.bassiana 
HO 
OH o 
# t 
I 
I o 2 
OH 
Scheme 4. Tyrosine and phenylalanine are both efficiently incorporated into tenellin 2 in 
B.bassiana. 
20 
In 2003 Schmidt et al. isolated militarinones B,C & D (14-16). This report was the first 
which shows the co-occurrence of these pyridone alkaloids and the related tetramic acids 
from the same species and thus has provided further evidence that the biosynthesis of 
these pyridone alkaloids proceeds via a tetramic acid intennediate and not via a 
rearrangement of phenylalanine. Tyrosine and the polyeneketo acid 23 (Scheme 5) 
would react to give the acyltetramic acid 15 (militarinone C) which would then be 
oxidised to the corresponding 6-hydroxy derivative 14 (militarinone B). Tetramic acids 
15 and 14 already bear a 4-hydroxy group at C-4' which is in disagreement with the 
hypothesis of a 4-hydroxylation being the initial step for ring expansion of the pyrrolidin-
2,4-dione but is in agreement with the incorporation of tyrosine suggested by Moore et al. 
Dehydration at C-5 and C-6 and tautomerization could lead to a quinone methide 
intennediate that would rearrange to the corresponding pyridone 16 (militarinone D). 
This compound could then undergo more reactions such as N-oxidation and further 
oxidation and reduction steps in the aromatic ring would lead to the cis-(1,4-
dihydroxycyc1ohexyl) moiety of militarinone A 13. 
+ #' #' ~ 0-
HO # RS 0 23 
0 OH ! 
#' #' 
HO ! Militarinone C 15 
0 OH OH 
~ #' #' ~ 
HO # 0 ! Militarinone B 14 
21 
0 OH 
# # 
HO 0 !+ 
OH 
~ 1 # # ~ 
#' ;J~ 0 
HO 1 
OH 0 
~ # # 
N 0 H 
MilitariDoDe D 16 
1 
HO 1 
OH 
OH 
~ # 
N 0 
I MilitariDoDe A 13 OH 
SchemeS. 
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1.4 Synthetic Routes 
In 1982 the first synthesis oftenellin 2 was reported by Williams and Sit.23 The ~-keto 
amine 25 was prepared in good yield (83.5%) from the phenyl ester 24 in 4 steps 
(Scheme 6). Selective saponification of 25 by lithiwn hydroxide was followed by 
treatment with 1,1' -carbonyldiimidazole to generate the reactive imidazolide 26. The 
lactam 27 was generated by internal acylation on treatment with sodiwn hydride. 
Oxidation with chloranil gave the pyridone 28. The benzyl groups were then 
hydrogenolysed to reveal the hydroxyl groups which were then protected as their THP 
ethers 29. Aldol reaction with LDA & E-2,4-dimethylhex-2-enal 30 afforded the 
hydroxyl adduct 31. Dehydration was accomplished quantitatively in anhydrous 
chloroform-triethylamine (4:1 by volume) in the presence of a catalytic amount of 
camphorsulfonic acid at reflux to give 32. Finally removal of the THP ethers afforded 
racemic tenellin 2. 
BnO 
4 Steps o 
• COOCH, 
x 
24 
25X=OCH, 
26 X=imidazoyl 
Bnilf'( 
j 
0 0 
NaH 
BnO 
'<:::::: OH 0 OH 0 
RO 
~ 
Chloranil 
I.LDA 
N 0 N 
I I OR OBn 
o 
2. 
H 28R=Bn 27 
29R=THP 
30 
23 
THPO 
OH 0 OH 
,;:::r 
N 0 
I 31 OTHP 
! CHCI, I NEt, 
CSA (cat) 
~ OH 0 
THPO 
# ,;:::r 
N 
I 32 OTHP 
l Deprotection 
HO 
0 
,;:::r 
N 32 
I OH 
TeneJIin 2 
Scheme 6. 
In 1989 a second total synthesis oftenellin 2 was reported by Rigby and Qabar.24 They 
used the cyclocondensation of a vinyl isocyanate to form the core pyridone ring. To form 
the vinyl isocyanate they began with commercially available 4-hydroxybenzaldehyde 33 
which could be converted to the protected carboxylic acid 34 in 3 steps. Conversion to 
the isocyanate 35 could then be effected through one of two methods (Scheme 7), either 
through exposure of 34 to diphenyl phosphorazidate (DPPA) in toluene followed by 
refluxing of the resultant acyl azide or by using the Weinstock mixed anhydride protocol 
to form the azide before thermolysis.25 
24 
Scheme 7. i. (PhOhPON3, Et3N, toluene, ii. EtOCOCl, Et3N, NaN3, toluene 
The synthesis of the right-hand fragment proceeded smoothly with p-keto ester 36 being 
prepared in 75% yield followed by subsequent conversion to the sodium salt 37 (Scheme 
8). Addition of the freshly prepared isocyanate 35 to this solution yielded pyridone 38 in 
70% yield from the p-keto ester. 
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37 
I)THF 
NCO 2)Ph2O 
Deprotection of the 2-methoxyethoxymethyl group proceeded using sodium iodide and 
trimethylsilyl chloride to give 39. Oxidation of the N-H bond to the hydroxamate N-OH 
functionality was accomplished first by O-silylating with hexamethyldisilazane 
containing a catalytic quantity of trimethylsilyl chloride to yield the extremely moisture 
sensitive 2,4-bis(silyloxy)pyridine derivative which was not isolated but treated 
26 
immediately with oxodiperoxymolybdenum(pyridine)(HMPAi6 complex in 
dichloromethane to yield the desired racemic tenellin 2 in 35% yield. 
There has only been one reported synthesis ofilicicolin H 4, also by Williams et al.,27 in 
which they have utilised a unique intramolecular Diels-Alder cyc1oaddition of a 
bis( diene) with very high regio and stereoselectivity (Scheme 9). Unsaturated aldehyde 
40 was reacted with the pyridone 28 previously reported by this group, in a Claisen 
condensation reaction to give the bis(diene) 41. Heating of 41 in o-dichlorobenzene 
yielded 42 as the main regio and stereoisomer via a Diels-Alder reaction. Treatment of 
42 with excess strong base promoted deprotonation of the benzyl ether at the nitrogen 
atom and subsequent loss of benzaldehyde to yield a net reduction at N-l. Finally 
removal of the remaining benzyl ether with boron trichloride yielded racemic ilicicolin H 
4 as confirmed by comparison with the natural product. 
BnO ~ -= OH 0 
.&" -= 
+ H 
0 ~ 
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0 R' 
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Scheme 9. 
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Dolle and Nicolaou have reported the first syntheses of the very challenging structures of 
the antibiotics aurodox 5 and efrotomycin 6 in their naturally occurring enantiopure 
fonns.1s Efrotomycin 6 and aurodox 5 were strategically divided into 8 key 
intennediates. The complexities of these targets required new methodologies for the 
stereoselective synthesis of the oligosaccharide segment of efrotomycin 6 and the 
stereocontrolled synthesis of the tetrahydrofuran segment of aurodox 5 and efrotomycin 
6. Synthesis of the pyridone fragment was completed using a previous literature method 
starting from readily available 4-benzyloxypyridine-I-oxide 43.19 The pyridine oxide 
was reacted with acetic anhydride to give 4-benzyloxy-2(1H)-pyridone which was then 
methylated on nitrogen using dimethyl sulfate to give 4-benzyloxy-I-methyl-2(1H)-
pyridone 44 (Scheme 10). Addition of the Vilsmeier reagent gave 3-formylation with 
complete regioselectivity to give the requisite benzyl protected pyridone 45. 
OBn OBn OBn 0 
~ 1.AczO ~ POCI3,DMF ~ H 
.. • 
+# 2. Me2S04. NaOH 
N N 0 
1- 1 0 Me 
43 44 45 
Scheme 10. 
A first total synthesis of racemic harzianopyridone 8 was completed in 1995 by Trecourt 
et al. 3o They utilised 2,3-dimethoxypyridine 46 as a starting material, converting it to 47 
in four steps (Scheme I I). Lithium-halogen exchange followed by reaction with 
trimethylborate-peracetic acid gave the 6-substituted derivative which isomerised to the 
more stable pyridone. Pyridone 48 was protected with the [2-
(trimethylsilyl)ethoxy)methoxy (OSEM) protecting group to give 49. Reaction of 49 with 
butyllithium followed by addition of E-2-methyl-4-hexenal gave the corresponding 
alcohol which was oxidised to the ketone 50 with PCC. Selective cleavage of the 
28 
carbamate protecting group with potassium hydroxide yielded the corresponding pyridine 
and conversion to harzionopyridone 8 was obtained by treatment of the pyridine with 
hydrochloric acid and methanol to remove the SEM group and give the natural product in 
9% overall yield using a 6-step sequence. 
M~)) MeO 4 Steps 
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Scheme 11. 
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In 2002 Baldwin et al. completed the synthesis of pyridovericin 11 via a biomimetic 
strategy from ready available 2,4-dihydroxypyridine 51.31 51 Was dibrominated at C-3 & 
C-5 and then bis-O-methylated to yield 52. Compound 52 was then reacted under 
Suzuki-type conditions with 4-benzyloxyphenylboronic acid 53, which was easily 
prepared from 4-bromophenol, to yield 54 as the major product (Scheme 12). 
29 
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Scheme 12. 
Compound 54 was then coupled with protected aldehyde 56. Compound 56 was prepared 
from diethyl-2-ethylmalonate 55 in 9 steps via a series of reductions, Swem oxidations 
and Wittig reactions (Scheme 13). Metal-halogen exchange of 54 followed by treatment 
with aldehyde 56 gave the desired alcohol 57 in 79% yield. Oxidation of 57 with 
manganese dioxide afforded the fully protected pyridovericin 58. Finally it was found 
after experimentation that in situ generated trimethysilyl iodide removed the methoxy and 
TBS protecting groups to give the diol which on treatment with boron tribromide resulted 
in of the benzyl group and the generation of racemic pyridovericin 11 in a total of thirteen 
steps for the longest linear sequence. 
30 
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Scheme 13. 
Although Baldwin et al. have reported the synthesis of pyridovericin 11, Curran et al. 
have also synthesised this compound using a quasi-racemic strategy.32 It was their 
intention to synthesise both enantiomers separately and also to assign the absolute 
configuration of pyridovericin 11. Although they failed in the former aim they were able 
31 
to assign the absolute configuration of pyridovericin 11 as R. Their method of synthesis 
was essentially that used by Rigby, utilising an isocyanate to form the pyridone ring and 
condensing with the appropriate aldehyde generated using the same conditions as 
Baldwin. 
Finally Irlapati and Baldwin have also published studies towards the biomimetic 
synthesis of pyridomacrolidin 12.33 The biosynthesis of pyridovericin 11 has yet to be 
elucidated although it reasonable to assume that it follows a similar pathway to that of 
tenellin 2 and bassianin 3. The biosynthesis of pyridomacrolidin 12 can be proposed 
from pyridovericin 11 via a number of steps (Scheme 14). 
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Scheme 14. (i) oxidation ofpyridovericin 11 to the hydroxamic acid 59, 
(H) further oxidation to the novel acyl nitrone intennediate 60, 
OH 
(iii) 1,3-dipolar cycloaddition with the natural product cephalosporolide B 61 
which has been isolated independently from the fungus Cephalosporium 
aphidicolcf4 but not as yet from B. bassiana. 
(iv) re-aromatisation to fonn pyridomacrolidin 12 by proton shift. 
1,3-Dipolar cyc1oadditions with nitrones of type 60 are not known to have been 
demonstrated, and as expected attempts to generate and trap unsubstituted quinoid 
species similar to 60 were unsuccessful, possibly due to competing additions to this 
highly electron-deficient centre. The authors therefore decided to block the phenolic 
ortho-positions by sterically hindered groups. 
Thus compound 68 was prepared via a modification of Williams strategy (Scheme 15). 
Firstly 62 was prepared from methyl propiolate in 4 steps, then saponified to give 63. 
This compound was activated with 1,1' -carbonyldHmidazole and the pyridone ring 64 
was then fonned on addition of sodium hydride. The pyridone was then oxidised and 
brominated to fonn 65 which was coupled with 66 (prepared from readily available 4-
bromo-2,6-di-tert-butyl-phenol) to yield 67 which was subjected to hydrogenolysis to 
give 68 in good yield. 
34 
(' 0 (" 0 LiOH,~O 
.. 
N 0 
N 0 I I 63 
OBn 62 OBn 1 CD!, THF, NaIl 
OH 0 OH 0 
Br ~ I. Pb(OAc)4 2. Br2 
• 
N 0 N 
I I 
OBn 6S OBn 64 
tBu 
HO ~ Suzuki conditions 66 
But ~ B(OH12 
tBu tBu 
HO ~ 
HO ~ OH OH 
But ~ But ~ ~ 
H2, PdlC 
.. 
N 0 0 
I 
OBn 67 68 
Scheme 15. 
35 
Oxidation of 68 with iodobenzene diacetate in the presence of 2-cyc1odecenone 69 
yielded the nitrone 70 which underwent [3+2]-cyc1oaddition with 69 to give the cyclised 
products phenol 71 and quinone methide 72 in 60% combined yield (Scheme 16). 
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Scheme 16. 
The formation of these compounds was rationalised by the formation of both exo and 
endo quinone methide adducts with the endo adduct able to undergo facile aromatisation 
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(Scheme 17) to fonn 71. The quinone methide adduct could be transfonned into the 
phenol by treatment with AlCI3 in DCE at relux.35 A possible biomimetic route to 
pyridomacrolidin 12 has thus been demonstrated. 
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1.5 Objective and Synthetic Strategy 
Having reviewed natural products which contain the 3-acyl-4-hydroxypyridin-2-one 1, it 
was our objective to synthesise these compounds and their analogues. 
The 3-acyl-4-hydroxypyridin-2-one 1 moiety is highly polar which leads to difficulty in 
handling and purification, so our strategy involves the use of isoxazoles to mask the 
enolised I,3-dicarbonyl moiety. The isoxazoles are synthesised via a I,3-dipolar 
cycloaddition of a nitrile oxide and an enamine?6 The weak N-O bond of the isoxazole 
73 can be cleaved in the last step of the synthesis to reveal the enolised tricarbonyl 
moiety (Scheme 18). The isoxazolopyridones can be envisaged as building blocks for the 
elaboration to natural and novel acyl pyridones. 
N 
H 
73 
1.5.11st Generation Approach 
;. 
1 
Scheme 18. 
In the first generation approach the Jones group used the amino acid p-alanine (Scheme 
19) as a starting material. This was protected with the N-benzyloxycarbonyl protecting 
group to give 74. The carboxylic acid was then activated with 1,1 '-carbonyldiimidazole 
and reacted with ethyl hydrogen malonate Mg-chelate formed from ethyl hydrogen 
malonate and propan-2-yl magnesium bromide to give the p-keto ester ethyl 5-
benzyloxycarbonylamino-3-oxopentanoate 75. The enamine of 75 was generated using 
pyrrolidine under Dean-Stark conditions and reacted with acetonitrile oxide generated in 
situ from nitroethane to form the isoxazole ethyl-5-(2-benzyloxycarbonylaminoethyl)-3-
methylisoxazole-4-carboxylate 76. The benzyloxycarbonyl group was removed with HBr 
in glacial acetic acid and the resulting hydrobromide salt 77 was basified which formed 
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the free amino group which spontaneously cyc1ised to fonn 3 methyl-4,5,6,7-
tetrahydroisoxazolo[4,5-c]pyridine-4-one 78. All of the natural products of the 3-acyl-4-
hydroxy-2-pyridone group contain a double bond between C-5 and C-6, which 
corresponds to C-6 and C-7 of the isoxazolo pyridone 78. A phenylselenation oxidative 
elimination approach was used to introduce this double bond. The isoxazolopyridone 78 
was reacted with LDA (2 equiv) to fonn the dianion which was reacted with 
phenylselenenyl chloride to fonn the phenylse1enide 79. The 7 -phenylselenyl group was 
then oxidatively removed with hydrogen peroxide and acetic acid to introduce the C-6,7 
double bond 80. 
~ ..... CO,H ___ ..... ~ 
ZHN/ ""-../ 
ii, iii 
CO,Et 
74 ZHN ZHN 
75 
PhSe 
7 vi 
• 
6 
~ 
79 
Scheme 19. Reagents: i, l,l'-carbonyldiimidazole, TIIF; then ethyl hydrogen malonate 
Mg-chelate; ii, pyrrolidine, toluene, reflux; iii, EtN02, Et3N, POCi); iv, HBr-AcOH; v, 
Na2C03 aq.; vi, LiNPt2 (2 eq.), TIIF, -78°C, PhSeCl; vii, H202, AcOH aq. 
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To validate the synthetic strategy the N-O bond of 80 was cleaved using catalytic 
hydrogenation (Scheme 20) followed by basic hydrolysis to reveal the enolised 
tricarbonyl moiety and afford 3-acetyl-4-hydroxypyridin-2-one 1 in 97 % yield over 2 
steps. 
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N 0 N 0 
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Scheme 20 
1.5.2 2nd Generation Approach 
The next part of our strategy was to elaborate at the C-3 methyl substituent of 78 in order 
to incorporate the side chains present in the natural products, however isoxazoles tend to 
undergo metaJlation and radical (H-abstraction) reactions at the C-5 substituent (C-7 in 
bicycle 78).37 Because N-O cleavage-hydrolysis of the isoxazole renders N-O 
regiochemistry irrelevant a revised strategy (Scheme 21, Path B) was looked at wherein 
the 4-carboxyisoxazole substitution is reversed. This simply interchanges the N and 0 
atoms of the fused isoxazole, the bicyclic isoxazole 78 of Path A is replaced by a 
dihydroisoxazolo[4,3-c]pyridine-4-one, and the 'isoxazole C-5' substituent is now at C-3 
of the bicycle 81. Path B reverses the origin of dipole and dipolarophile relative to path 
A, this time using the regiospecific addition of a ~-aminonitrile oxide to the enamine of a 
~-ketoester. 
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Thus starting with the N-benzyloxycarbonyl protected ~-alanine methyl ester 82 (Scheme 
22), reduction to the aldehyde 83 followed by reaction with hydroxylamine hydrochloride 
yields cis and trans isomers of the oxime 84. Chlorination of the oxime yields the 
chlorooxime 85, which on treatment with triethylamine generates the nitrile oxide in situ 
which can undergo 1,3-dipolar cyc1oaddition with the pyrrolidine enamine 86 of ethyl 
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acetoacetate, followed by spontaneous elimination of pyrrolidine to give the 3-(2-
benzyloxycarbonylaminoethyl)isoxazole-4-carboxylate 87. Removal of the N-protecting 
group gave the amine HBr salt 88 which on basification underwent spontaneous 
cyclisation to the isoxazole[4,3-c] pyridine 81. The double bond needed between C-6 
and C-7 of 81 could not be inserted via C-7 deprotonation followed by the 
phenylselenation-oxidative elimination sequence employed in the 1 sI generation 
approach, as the metallation reactivity is now transferred to the C-3 substituent of the 
bicycle 81. Therefore a number of different methods were looked at which were largely 
unsuccessful, but eventually an N-halogenation-dehydrohalogenation approach was 
looked at. Thus lactam 81 was treated with tert-butyl hypochlorite in the absence of 
direct light to give N-chlorolactam 89 which was then subjected to photolysis (medium-
pressure Hg lamp) to afford the isoxazolopyridone 73. However, the elimination product 
was formed in roughly equal amounts with dechlorinated material 81. 
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Scheme 22. Reagents: i, DIBAL-H, toluene, -78 ·C; ii, NH20H.HCl, NaOAc, EtOH aq., 
70 ·C; iii, N-chlorosuccinimide, CHCi); iv, Et3N; v, HBr-AcOH, 20 ·C; vi, Na2C03 
aq.; vii, tert-BuOCl, MeOH, 0 ·C; viii, hv (medium-pressure Hg lamp, quartz vessel), 
MeOH. 
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1.5.3 3rd Generation Approach 
In this thesis, we will describe our development of an improvement to the 2nd generation 
approach which allows for a simpler route to the isoxazole bicycle 73. We have used this 
method to synthesise the bicycle 73 which can be used as a building block to progress to 
a specific natural product containing the 3-acyl-4-hydroxypyridin-2-one unit. We have 
43 
looked at methods for elaborating at the C-3 & C-7 positions of this building block to 
incorporate the conjugated alkene side chains and the para-hydroxyphenyl group present 
in the majority of these natural products, and finally we have made progress towards the 
natural product tenellin 2. 
44 
Chapter 2 Results & Discussion 
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2.1 Current Approach 
The 2nd generation approach has been modified due to the difficulties encountered when 
trying to insert the double bond between C-6 & C-7 in isoxazolopyridone 81. The 
proposed starting material now becomes a diaminocarboxylic acid which will result in a 
free amino group being present at the C-7 position of 81. Our plan was that this group 
could be removed via diazotisation which involves converting the amine into a nitrogen 
leaving group which is then lost as a gas to leave a cation. We anticipated that 
spontaneous proton loss from the C-6 position would follow and the required double 
bond between C-6 & C-7 would be formed. The starting material is thus the 
commercially available racemic 2,3-diaminopropionic acid mono hydrochloride (It is 
stored as the mono hydrochloride salt as it is unstable as the free diamine). Esterification 
of the carboxylic acid followed this time by di-tert-butyloxycarbonyl protection of the 
two amino groups will yield the di-tert-butyloxycarbonyl protected ester (Scheme 23). 
Reduction of this ester to the aldehyde again via DIBAL-H followed by reaction with 
hydroxylamine hydrochloride will yield the required oxime. Chlorination of the oxime 
and reaction with triethylamine will yield the nitrile oxide in situ. The nitrile oxide is 
then reacted with the pyrrolidine enamine of ethyl acetoacetate via 1,3-dipolar 
cycloaddition to form the isoxazole 90. Thus the first target in this project became 
synthesis of the isoxazole 90 via a 1 ,3-dipolar cycloaddition. 
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2.2 The 1 ,3-Dipolar Cycloaddition reaction 
This reaction involves the concerted cyc1oaddition addition of a 1,3-dipole to a 
dipolarophile. The 1,3-dipole contains three atoms with four pi electrons delocalised 
over the three atoms. There are two types (Scheme 24), either with an orthogonal double 
bond (type I) or without (type 2).38 
(1) 
+ 
x=y-Z (2) 
L 
~y ........... -
X Z 
Scheme 24. The two types of 1,3-dipole: (I) with an orthogonal double bond 
and (2) without an orthogonal double bond 
Below (Scheme 25) are representative examples of both types of 1,3-dipole. 
+ 
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+ -/ 
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+ 
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Scheme 25. Examples of both types of 1,3-dipole 
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nitrones 
azomethine imides 
azomethine ylides 
Compounds which can react with 1,3-dipoles are known as dipolarophiles, and contain 
double or triple bonds with examples being vinyl ethers, enamines and simple alkene or 
alkyne double and triple bonds. 
The 1,3-dipolar cycloaddition is thought to be a concerted process which proceeds 
through an unsymmetric transition state, implying that the formation of one sigma bond 
may be more advanced than the other. The regio and stereoselectivity can be explained 
by frontier molecular orbital theory.38 This theory proposes that the reaction proceeds 
through a cyclic transition state which is favoured if there is a favourable interaction 
between the highest energy filled pi orbital (HOMO; highest occupied molecular orbital) 
of one reactant and the lowest energy empty pi orbital of another reactant (LUMO; lowest 
occupied molecular orbital). Reactant orbitals must be of the correct phase, the approach 
sterically feasible and the pi orbital interactions are stronger if they are closer in energy. 
The reaction is thus favoured if one reactant is strongly nucleophilic and the other 
reactant is strongly e1ectrophilic. Electrophilic dipolarophiles tend to have a low energy 
LUMO whilst nucleophilic dipolarophiles tend to a have high energy HOMO. Therefore 
for a given 1,3-dipole the dominant interaction is likely to be type I (Scheme 26) for 
dipolarophiles with electron withdrawing groups but type 2 for dipolarophiles with 
electron-donating groups like enamines or enol ethers. The reactivities of 1,3-dipoles 
towards various types of dipolarophile varies widely and can be understood by comparing 
frontier orbital energies. HOMOILUMO interactions are strongest where the energy gap 
of orbitals is smallest. 
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2.2.1 Regioselectivity 
There is often considerable regioselectivity in 1,3-dipolar cycloadditions with 
predominantly or exclusively one regioisomer formed. Electronic effects are the major 
factor but steric effects can have an influence. For example in the reaction between 
diazomethane and methyl methacrylate (type 1) only regioisomer (1) is formed (Scheme 
27). This can be explained by stating that the more favourable product to be formed is 
that which results from interaction between the larger orbital coefficients in the relevant 
HOMO and LUMO. The frontier orbital coefficients for a large number of dipoles and 
dipolarophiles have been calculated which allows the regioselectivity of a range of 
cycloadditions to be predicted. 
Cl --P HOMO t
N
"8 
Me 8-kMe Me C02Me LUMO " C02Me Me02C 
(1) (2) 
Scheme 27. HOMO-LUMO interactions leading to formation of (1) 
2.2.2 Stereoselectivity 
The stereochemistry of the original dipolarophile is represented in the product, and this is 
strong evidence of a concerted mechanism. The stereoselectivity makes the 1,3-dipolar 
cycloaddition a very important synthetic tool, although this is not significant in this 
project since we are making planar aromatic isoxazoles. 
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2.3 Synthesis of 1 st Target Isoxazole 90 
2.3.1 Esterification 
Commercially available racemic 2,3-diaminopropionic acid hydrochloride 91 was 
esterified to form the methyl ester 92 using methanol and acetyl chloride to generate the 
acid catalyst in excess (Scheme 28). Both methanol and acetyl chloride were distilled 
and then used immediately, heating under reflux was continued for up to 7 days 
(depending on the amount of starting material used, larger amounts tending to need more 
time) after which time the reaction was judged as not to have gone to completion by the 
two distinct C-2 protons of product and reagent in the IH NMR spectra. The reaction was 
repeated for a further period of again up to 7 days with fresh portions of methanol and 
acetyl chloride by which time the C-2 proton signal of2,3-diaminopropionic acid 91 was 
adjudged to be absent and the reaction therefore reasoned to have gone to completion. 
On some occasions the reaction was again adjudged as not to have gone to completion 
and therefore had to be repeated a third time; this tended to happen when using larger 
amounts of starting material e.g. 15 or 20 g. The handling of both starting material and 
product proved to be troublesome with both being very insoluble in methanol and loss of 
material occurred during the reaction due to decomposition and therefore the yields were 
variable between 65-90%. Unreacted starting material could be taken through to the next 
step (protection of the amine groups) but the work up had to be altered. This involved 
washing with more base to remove the excess carboxylic acid of the starting material. 
2.3.2 Amine group protection 
Protection of the two amino groups using the tert-butyloxycarbonyl (Boc) protecting 
group proceeded smoothly under standard conditions using triethylamine and di-tert-
butyl dicarbonate with stirring at room temperature overnight. However observation of 
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the IH NMR spectrum indicated the presence of unreacted di-tert-butyl dicarbonate that 
could not be removed by silica column chromatography or on the rotary evaporator even 
though the boiling point of di-tert-butyl dicarbonate is only 63°C. One possible 
explanation is that this is due to the presence of very strong intermolecular bonding 
between di-tert-butyl dicarbonate and the Boc protected ester 93. The best way to 
remove the di-tert-butyl dicarbonate was to leave the ester 93 under high vacuum for a 
few days (or weeks), but this was a very tiresome method of removal and the presence of 
unreacted di-tert-butyl dicarbonate did not cause any noticeable problems in the 
reduction of the ester to the aldehyde in all subsequent syntheses, and therefore the 
unreacted di-tert-butyl dicarbonate was not removed. 
2.3.3 Oxime formation 
Reduction of the ester 93 to the aldehyde 94 with DlBAL-H at -78°C in toluene 
proceeded smoothly and progress could be checked by looking for the aldehyde hydrogen 
signal in the IH NMR spectrum, although this was usually not necessary. The aldehyde 
was then dissolved in the minimum volume of ethanol and immediately reacted with 
hydroxylamine hydrochloride in sodium acetate and water to afford the oxime 95 in high 
yield (70-90%) (Scheme 28). Both syn and anti oximes were produced and it was 
possible to isolate both isomers via column chromatography. The oxime will crystallize 
from solution if left in the fridge overnight but the absolute minimum volume of ethanol 
must be used. If crystallisation did not occur, column chromatography was used to purify 
the oxime or it was simply extracted from the aqueous solution using dichloromethane or 
chloroform. The oxime was dried with phosphorus pentoxide under vacuum overnight 
prior to being reacted further. 
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Scheme 28. Reagents: i, methanol, acetyl chloride, reflux; ii, NEt3, di-tert-butyl 
dicarbonate, DCM, RT, 24 h; Hi, DIBAL-H, toluene, -78°C, I h; iv, NH20H.HCI, 
NaOAc, EtOH aq., 70 ·C. 
2.3.4 Isoxazole synthesis 
To generate the required nitrile oxide the oxime had to be converted into the chloro-
oxime 96 (Scheme 30). This was achieved by treatment with two portions ofNCS and 
heating under reflux overnight; the reaction was then checked by tic to ensure 
completion. The chloro-oxime 96 could either be converted in situ to the nitrile oxide 97 
or subjected to work up and isolated to remove any charged impurities which could 
hinder the cycloaddition. The chloro-oxime 96 was then treated with the pyrrolidine 
enamine 86 of ethyl acetoacetate (prepared from ethyl acetoacetate and pyrrolidine 
[Scheme 29] under Dean/Stark conditions) and triethylamine. The triethylamine removes 
the hydroxy proton from the chloro-oxime and forms the nitrile oxide 97 by loss of 
chloride. The dipole then adds to the enamine via a 1,3-dipolar cycloaddition with 
spontaneous elimination of pyrrolidine to give the required isoxazole 90 (Scheme 30). 
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Scheme 29. 
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Synthesis of the isoxazole proved to be a real "bottleneck" in terms of yield (30-50% was 
common) and failure of the reaction in the first few instances. This is in part due to the 
unpredictable nature of nitrile oxides which are extremely reactive species and will tend 
to react with the first molecule they encounter (Le. themselves), hence we opted to use 
four equivalents of enamine to increase the chances of reacting with the desired species 
(any more enamine and purification of the isoxazole would become more difficult), also 
the triethylamine is added dropwise to ensure the concentration of the nitrile oxide is kept 
to a minimum. The fust attempt to yield isoxazole presented a meagre 8% yield after 3 
chromatography colunms to purify the product, while the second attempt failed to 
generate any isoxazole at all, however on obtaining advice from a previous student a few 
changes were made to the procedure in an attempt to increase the yield. Passing the 
reaction solvent, chloroform, through alumina in order to remove ethanol and HCI 
(distilled DCM was also used as an alternative), drying and distillation of the 
triethylamine, removal of water from the oxime or chloro-oxime and conducting the 
whole reaction in an inert atmosphere did increase the yield to around 60% which we 
considered very reasonable given the high reactivity of nitrile oxides. 
Every effort was made to keep water out of the reaction, although removal of water from 
the oxime could be difficult in part due the solid state of the oxime. With it being a 
mixture of cis/trans isomers it is a very a sticky gel-type material which makes handling 
difficult; isolation of one isomer via chromatography gives a white solid which is easier 
to handle although the reaction was never conducted with just one diastereoisomer. 
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Scheme 30. Isoxazole formation 
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2.4 Synthesis of Isoxazolopyridone 73 
Having made the isoxazole the next step was to fonn the pyridone ring. This involved 
removal of the Boc groups, followed by ring closure and finally insertion of the double 
bond present between C-6 & C-7 of 73 by diazotization. 
The Boc groups could be easily removed by treatment of isoxazole 90 with excess TF A 
and stirring at room temperature for 4.5 h to give the bis(trifluoroacetate) salt 98 which 
on treating with 2M HCl for 30 min gave the dihydrochIoride salt 99 in 99% yield 
(Scheme 31). 
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Scheme 31. 
Treatment of this salt with aqueous sodium carbonate fonns the diarnine 100 which 
spontaneously closes via the primary amine to give the six membered lactam ring 101 in 
72% yield. It is of course feasible that secondary amine could ring close resulting in 
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formation of the five membered lactam ring but this would be thermodynamically 
unfavourable due to the extra strain involved on the sp2 carbons. The reluctance of such 
5-membered lactarns to form from the amino esters, is well known from work in our 
research group from acyitetramic acids. ss The six membered lactam 101 was then 
extracted from the aqueous layer by repeated washings with either warm DCM or warm 
ethyl acetate. The dihydropyridone was then treated with sodium nitrite and 2M HCI in 
water at 0 ·C for 1 h and then at 50 ·C for 1 h to form the isoxazolopyridone 73 via 
diazotization with loss of nitrogen, formation of the cation and elimination of If' from C-
6 to form the double bond between C-6 & C-7. It is of course possible that water could 
attack the cation resulting in a hydroxy ion at C-7 and indeed this does occur but only to a 
very small extent It is much more favourable to form the double bond due to the extra 
conjugation and hence stability 73. Alternatively to avoid repeated extraction of the very 
water soluble free amine the diazotization reaction can be carried out in the same pot 
resulting in a slightly increased yield (71 % overall) and the isoxazolopyridone product 
could then be extracted from the aqueous layer by washing with DCM a couple of times. 
2.5 Revealing the enolised tricarbonyl moiety 
Having made the isoxazolopyridone the next step was to justify our strategy and reveal 
the enolised tricarbonyl moiety. This had been done previously using hydrogenolysis, 
but this would be inapplicable to a natural product synthesis because the natural products 
contain double bonds in the side chain. We therefore looked at something that would be 
selective for the isoxazole N-O bond and found that molybdenum hexacarbonyl had 
previously been used to open isoxazole N-O bonds.39 The isoxazole was treated with an 
equimolar quantity of molybdenum hexacarbonyl in undistilled acetonitrile and the 
solution heated at refux for 4 h to give enarninone 102 (Scheme 32). The amino group 
was then converted into the hydroxypyridone via diazotization to reveal the enoJised 
tricarbonyl moiety 1 in 90% yield from 102. This demonstrated the viability of the 
masking strategy. 
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Scheme 32. 
The proposed mechanism for N-D bond cleavage is shown below (Scheme 33). Firstly 
the molybdenum complexes to the nitrogen atom, the N-D bond breaks forming a nitrene 
complex which is then hydrolysed to give the enaminone 102. 
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Scheme 33. 
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We used undistilled acetonitrile as it is believed that small quantities of water present in 
the solvent help to hydrolyse the molybdenum complex. 
2.6 Elaboration at the C-3 Methyl position of 73 
It was our intention to use isoxazolopyridone 73 as a building block to a variety of natural 
and unnatural products and therefore we needed to look at elaborating at the C-7 & C-3 
(methyl) positions of isoxazolopyridone 73. It has been shown that isoxazoles tend to 
undergo metallation reactions at their C-5 substituent40 (C-3 in isoxazolopyridone 73) and 
we therefore reasoned that we may be able to utilize anion chemistry on the methyl 
substituent of 73 using a suitable base followed by quenching with an appropriate 
electrophile. 
C-7 
"-,... 
C-3 
I 
N 0 
H 
73 
2.6.1 Development of method for C-3 elaboration 
The first base we looked at was LDA (generated in situ from n-butyllithium and di-
isopropylamine) with methyl iodide as an electrophile. We initially used 2.2 eq. ofLDA 
at -78 °C (presuming that the amide proton is more acidic than the methyl group, an extra 
equivalent of base is necessary to remove the NH proton first) with an excess of methyl 
iodide. This resulted in the fonnation of the 3-ethyl 103 showing that of the two 
potentially reactive centres (Le. nitrogen or C-3 methyl) reaction is preferred at the C-3 
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methyl position (Scheme 34). There was no evidence in the lH NMR spectrum for 
reaction at the nitrogen. No yield could be obtained for 103 because purification via 
chromatography was very difficult due to the similarity of starting material and product. 
We therefore looked at the same reaction but with a different electrophile, benzaldehyde. 
This time we tried with 3 eq. of LDA at -78°C and again an excess of electrophile and 
isolated only the hydroxy adduct 1 04 (as opposed to the eliminated product) and a small 
amount of starting material but unfortunately the yield was only 17%. 
N-O 
r ~ I. LDA2.2 eq _78°C 
• 
2.MeI 
0 N 0 
H 
73 103 
N-O N-O OH 
~ f ~ ~ I. LDA3 eq -78°C Ph 
• 
2. PhCHO 
0 N 0 
H 
104 
17% 
N-O 
I. MeOW ~ ~ NaOMe 3 eq reflux ~ Ph 
• 
2.PhCHO 
0 N 0 
H 
105 
8% 
Scheme 34. 
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In our group a colleague has also been working on the related five membered ring 
tetramic acids using the same isoxazole methodology and from this work it has been 
shown that we can use thermodynamic conditions to elaborate at the C-3 methyl group, in 
this case using sodium methoxide.57 This approach would however not be applicable to a 
natural product synthesis, as for example with tenellin 2 we would need an enolisable 
aldehyde (in this instance E-2,4-dimethylhex-2-enal) and therefore thermodynamic 
conditions would not work, but we decided in any case to look at this reaction in the 
pyridone series with the non-enolisable benzaldehyde. Addition of three equivalents of 
sodium methoxide in methanol and an excess of benzaldehyde followed by refluxing for 
1 h resulted in the formation of the eliminated product 105 in 8% yield and starting 
material; no hydroxy adduct product was observed. 
To obtain only 17% yield of the hydroxy adduct 104 with 2.2 eq ofLDA and an excess of 
benzaldehyde was disappointing. We therefore decided to repeat this reaction using 
different conditions. We tried using 2.2, 5 and even 10 eq. of LDA but still managed 
only around 20% yield with a maximum of23%. Further recrystaIisation of the isoxazole 
and distillation of the benzaldehyde made no difference. We suspected that the base 
might insufficiently concentrated but analysis of the presumed 2.5M n-butyllithium 
solution by titration showed it to be just less than 2.5M which would make no difference 
to the yield. 
Having failed to increase the yield from 23% we therefore reasoned that the low yield 
may be in part be due to the fact we are forming a dianion, one equivalent of LDA 
removes the amide proton forming a negative species and the second equivalent ofLDA 
is therefore attacking a negative species, which we believe would slow the reaction rate 
down. Protection of the amide nitrogen with for example the Boc protecting group will 
eliminate this problem. 
It was therefore decided to protect the amide nitrogen with the Boc protecting group and 
then to attempt the condensation reaction. Protection of the amide functionality (Scheme 
35) was achieved in 86% yield (which is slightly surprising given the low reactivity of 
amides) using one equivalent of LDA at -78°C and one equivalent of di-tert-butyl 
dicarbonate to yield 106. The next stage was then to attempt reaction at the C-3 methyl 
position of the protected amide with benzaldehyde. This was attempted a number of 
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times using 1.1 eq. and 2.2 eq of LOA -78 °C with an excess of benzaldehyde and on 
each occasion only a small proportion of product 104 (ca. 5%) was obtained with 
concurrent loss of the Boc protecting group in the acidic work up. We therefore decided 
to look at other options. 
1. LDA 1.1 eq _78°C 
• 
2.B~O 1.1 eq -78°C 
73 
Scheme 35. 
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Having failed to increase the yield of the aldol coupling reaction with LOA it was 
decided to try another base and the first base we looked at was n-butyllithium. We were 
initially reluctant to try n-butyllithium as we thought it may act as a nucJeophile and 
potentially attack the isoxazole ring. The first attempt with n-butyJlithium used a slight 
excess of the base (4 eq.) at -78 °C with a large excess of benzaldehyde and surprisingly 
this resulted in a big increase in yield to 55% of the hydroxy adduct 104. Only the 
hydroxy adduct and a small amount of starting material 73 were isolated after 
chromatography suggesting the remaining material has decomposed to polar by products. 
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To see if 4 eq. of base was necessary the reaction was repeated with 2.2 eq and this led to 
a further improvement in yield, this time to 63%. 
So having developed a method for elaboration at the C-3 methyl position with 
benzaldehyde and having achieved an acceptable yield we decided to look at other 
aromatic & aliphatic aldehydes. 
2.6.2 Application of method to other aromatic & aliphatic aldehydes 
We first decided to try with the C-3 chain extension with other aromatic aldehydes 
(Scheme 36) using the same conditions i.e. 2.2 equivalents of butyllithium at -78 °C 
before aldehyde addition. Reaction of the 3-methylisoxazolopyridone 73 with 4-
nitrobenza1dehyde and cinnamaldehdye gave better yields of 89 & 84% respectively 
which is to be expected due to the increased electron withdrawing character of the nitro 
& styryl groups, likewise reaction with 4-methoxybenzaldehyde gave a slightly decreased 
yield of 61 % which again is to be expected due to the electron donating character of the 
methoxy group making the aldehyde less electropositive. 
Again on each occasion only the hydroxy adducts and a small amount of starting material 
were isolated, no eliminated product was detected which is perhaps surprising especially 
in the reaction with cinnamaldehyde in which loss of water would lead to a product that 
would be more stable through increased conjugation. 
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Scheme 36. 
The natural products isolated so far do not contain aromatic C·3 side chains so therefore 
we decided to try coupling isoxazolopyridone 73 with some aliphatic aldehydes. Firstly 
we tried with crotonaldehyde & tiglic aldehyde which are both commercially available 
and, this gave very good yields of97 & 70% respectively (Scheme 37) and again only the 
hydroxy adducts and a small amount of starting material were isolated. 
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Scheme 37. 
An X-ray crystal structure of the crotonaldehyde adduct 110 has been obtained and is 
shown below (X-Ray 1). This verifies the structure of the hydroxy-adduct. 
X-Ray 1. 
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The coupling with crotonaldehyde and tiglic aldehyde proved successful so our next step 
was to try the coupling reaction with the aldehyde that would lead to the natural product 
tenellin 2, which is E-2,4-dimethylhex-2-enal 30. This aldehyde is not commercially 
available and therefore had to be synthesised via a literature procedure (Scheme 38).22 
Firstly propanal was added dropwise to tert-butylamine to form imine 112, which was 
then lithiated using n-butyllithiurn at -78°C and reacted with 2-methylbutryaldehyde 
113. 2M Citric acid was added and the reaction mixture stirred vigorously overnight to 
give the enal 30 after chromatography in 37% yield overall from propanal. 
But 
""N 
• H~ 
112 
o 
+ I. n-BuLi -78°C 
• 
H H 
113 30 
Overall 37% 
Scheme 38. 
E-2,4-Dimethylhex-2-enaI 30 was used immediately and reacted with the isoxazole 73 
using the same conditions that had been used for the other enals to give the hydroxy 
adduct 114 in 60% yield (Scheme 39). 
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So having developed a method for elaboration at the C-3 methyl position of the pyridone 
73 and performed a number of reactions with both aromatic and aliphatic aldehydes 
(including the aldehyde that would lead to the natural product tenellin 2), forming in each 
case the hydroxy adduct, the next step was to look at dehydration of these compounds to 
introduce the double bond required in the natural side chains. 
2.6.3 Dehydration & ring opening on model compounds 
We first tried dehydration on the benzaldehyde adduct 106 using para-toluenesulfonic 
acid (1.1 eq.) under reflux in toluene overnight; this gave incomplete conversion by TLC 
and therefore the process was repeated for a further 24 h until the starting material had 
disappeared by TLC. Unfortunately although the reaction had gone to completion by 
TLC not all of the material was recovered indicating some decomposition of starting 
material or product. The dehydrated product 115 was however isolated in 71 % yield. 
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The same process was repeated on the further aromatic hydroxy adducts 108 and 109 
(Scheme 40) until the reactions had gone to completion by TLC, to produce the alkenyl 
isoxazolopyridones 116 and 117 in 99% and 100% yields, respectively. In the case of the 
4-nitrobenza1dehyde adduct 107 no dehydration to afford 118 was observed using these 
conditions. 
N-O OH N-O 
I 
,/ I ~ ~ ~ ~ p-TSA 
• ~ Toluene! ~ 
0 Reflux N 0 H 
106 US 
N-O OH N-O 
I 
,/ ~ r Ph ~ ~ ~ Ph 
p-TSA 
• 
Toluene! N 0 Reflux N 0 H H 
108 116 
N-O OH N-O 
I p-TSA I ~ • ~ ~ Toluene! ~ ~ 
Reflux 
~ OMe ~ N 0 OMe 
H 
109 117 
Scbeme40. 
After a second attempt to dehydrate the 4-nitrobenzaldehyde adduct and still not 
succeeding, other methods were examined. Another acid was used, hydrochloric acid 
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generated using methanol and acetyl chloride. Although this acid is of similar strength to 
para-toluenesulfonic acid, around 10 equivalents of methanol and acetyl chloride were 
used making the solution a lot more concentrated, however this again failed to generate 
any of the eliminated product after 24 h heating at reflux. Having failed to get the 
reaction to work using acid conditions we decided to look at basic conditions. An 
attempt to effect dehydration using sodium methoxide (3 eq.) in methanol at reflux was 
made but this again led only to isolation of starting material (Scheme 41 & Table 1). Our 
next option was to convert the hydroxy group into a leaving group (by reaction with ego 
mesyl chloride) and then treat the compound with a weak base (eg. triethylamine), 
however with the amount of the 4-nitrobenzaldehyde recovered being a lot less than that 
with which we had started, we decided to proceed with other reactions and possibly make 
more of the 4-nitrobenzaldehyde adduct later in the project 
It is believed in the case of acid catalysed dehydration the process goes via an El 
mechanism forming a cation a to the phenyl group. This would be highly unfavourable 
next to an aromatic ring carrying an electron withdrawing group like the 4-nitro group but 
more favourable next to an aromatic ring carrying an electron donating group like the 4-
methoxy group. This would explain why dehydration has proved troublesome in the case 
of the 4-nitrobenza1dehyde adduct, in agreement with what we have observed. 
N-O OH N-O 
~ 
~ ~ # ~ 
#' NO, #' 0 0 N02 
107 118 
Scheme 41. 
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Reagents Quantity (eq.) Temp("C) 
p-TSA, Toluene 1.1 no 
p-TSA, Toluene 2.2 no 
AcCl,MeOH l.l 65 
NaOMe,MeOH 3.3 65 
Table 1. 
Having successfully dehydrated the aromatic aldehyde adducts (with the exception of the 
4-nitrobenzaldehyde adduct) we decided to try and dehydrate the aliphatic aldehyde 
adducts 110, 111 and 121 (Scheme 42). 
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Scheme 42. 
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The same acidic conditions (p-TSA, toluene, reflux) were again used, on this occasion the 
reactions proceeded to completion by TLC after just 24 h which may be as a result of 
improved solubility, the aromatic hydroxy adducts being less soluble. Although the 
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reactions proceeded to completion by TLC, isolated yields of alkenes 119, 120 and 121 of 
33, 90 and 32% were recorded so we presume that the remaining material decomposed. 
The yield of 90% for the formation of alkene 120 is a lot higher than the other two and it 
may be because this was recorded just after working up the reaction as the products (119, 
120 and 121) were found to be unstable in air unless stored in the refrigerator under 
nitrogen. In conclusion although para-toluenesulfonic acid in toluene at reflux is an 
effective method for dehydration of these compounds the conditions are too harsh and 
can lead to decomposition of products, therefore alternative conditions will need to be 
looked at in future in order to increase the yield. 
Having successfully dehydrated all but one of the hydroxy adducts we decided to look at 
isoxazole ring opening on an aromatic and aliphatic side chain example. So compound 
116 was treated with molybdenum hexacarbonyl in undistilled acetonitrile for 4 h under 
reflux followed by chromatography on silica gel to give ketoamine 122 (Scheme 43) in 
32% yield. Although the reaction was successful purification proved difficult with the 
basic compound tending to stick to the silica gel and requiring a high percentage of 
methanol:DCM to remove it from the column. The reaction was repeated under the same 
conditions using diene 121 to give ketoamine 123 but this time alumina chromatography 
was used to purify, resulting in an increase in yield for ring opening to around 96% with 
all the compound being removed from the column. 
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Scheme 43. 
An attempt was made to convert enaminone 123 into the corresponding enolised 
tricarbonyl 124 (Scheme 44) with the same conditions used previously for diazotization 
of the 7-amino compound 101 but this was unsuccessful and the harsh conditions used 
resulted in decomposition of the starting material. Other methods for this conversion will 
have to be examined in future work. 
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2.7 Elaboration at the C-7 position 
Having developed a method for elaboration at the C-3 methyl group, we next had to look 
at developing a method for elaboration at the C-7 position to incorporate the para-
hydroxyphenyl grouping present in many of the natural products. The two main options 
open to us were to use the StiIIe reaction or the Suzuki reaction; we decided to look at the 
Suzuki reaction due to the reagents involved being less toxic than the tin compounds 
involved in the StiIIe protocols, and also because the starting materials were more readily 
available. 
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2.7.1 The Suzuki reaction 
The Suzuki reaction involves the coupling of an aryl, alkenyl or alkynyl halide or triflate 
with an aryl, alkenyl or even alkyl boron compound in the presence of a Pd(O) catalyst 
and base.41 The reaction proceeds under mild conditions with no toxic by-products and is 
selective, generally proceeding in the presence of a variety of functional groups. It is 
these qualities which make this reaction very useful in organic synthesis. The postulated 
mechanism is shown in scheme 43 for an aryl-aryl coupling.42 
It is believed that the coordinatively unsaturated Pd°<L2) complex is the likely catalytic 
species.43 The mechanism is similar to that of other palladium-mediated couplings (eg 
Heck, Stille). Initial oxidative addition of the palladium into the carbon-halogen bond is 
followed by reaction of the Pd(II) complex with a boron compound such as an 
arylboronic acid, with transmetallation of boron for palladium to form a trans-
diarylpalladium(II) species. 
The boron species involved in transmetallation is most likely a boron anion, formed by 
reaction of a B(III) reagent with hydroxide or with the base anion present. It has been 
shown that the boron anion is 106 times more reactive than the neutral boronic acid in 
electrophilic reactions. Isomerisation of the trans isomer to the cis is followed by 
reductive elimination of the coupled product, regenerating the Pd(O) catalyst. 
Mechanistic studies have been conducted using ESI mass spectrometry techniques which 
have confirmed the presence of intermediates 125 and 126, but other intermediates have 
not been detected and the exact nature of transmetallation is still not yet known. 
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2.7.2 Halogenation at C-7 of isoxazolopyridone 73 
The rate of oxidative addition of an alkenyl or aryl halide to palladium has been shown to 
increase in the order I > Br > Cl so we therefore set about putting an iodine substituent on 
C-70f73. Firstly an attempt was made with simply molecular iodine by stirring at room 
temperature overnight (Scheme 46) but this led only to recovery of starting material. The 
reaction was repeated by refluxing in DCM overnight but again led only to isolation of 
starting material. We then looked at iodine monochloride which is a more electropositive 
source of electrophilic iodine and this proved successful with stirring at room temperature 
for three days to form the 7-iodoisoxaozlopyridone 127 in 64% yield. 
N-O 
r ~ 12 
.. No Reaction 
N 0 
H 
73 
N-O 
r ~ lel 
.. 
N 0 
H 
127 
Scheme 46. 
2.7.3 Synthesis of the boron reagent 
The natural products contain apara-hydroxyphenyl group at the c-s (C-7 of 73) position 
so we therefore decided to look at inserting the benzyl protected hydroxyphenyl group 
which will require 4-benzyloxyphenylboronic acid as the Suzuki coupling partner. Our 
ultimate aim is to make a natural product from isoxazolopyridone 73 so we intend to 
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elaborate at the C-7 position of 73 and then try condensation at the C-3 position with an 
aldehyde that would lead to a natural product, so we believed it necessary to have the 
hydroxy group on the phenyl ring protected in order for our anion chemistry to be 
successful. 
We decided to make 4-benzyloxyphenylboronic acid ourselves even though it is 
commercially available. Firstly para-bromophenol 128 was reacted with benzyl bromide 
in the presence of potassium carbonate (Scheme 47) to give 4-benzyloxybromobenzene 
129 in 84% yield.44 This was then reacted with n-BuLi to form the benzyloxyphenyl 
lithium 130, via lithium-halogen exchange, which was then reacted with 
triisopropylborate and the borate ester hydrolysed with water to give 4-
benzyloxyphenylboronic acid 131 in 88% yield.4s 
OH OBn 
Br Br 
128 129 
! n-BuLi 
OBn OBn 
• 
Li 
130 
131 
Scheme 47. 
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2.7.4 Development of a Suzuki reaction to elaborate at C-7 
Having both precursors in hand we decided to go ahead with the Suzuki reaction, but 
looking at the literature it became clear that there were numerous methods for doing this 
with many different catalysts, bases, solvents etc used previously, so we decided fIrstly to 
look at the most commonly used conditions. This involved using palladium 
tetrakis(triphenylphosphine) as the Pd(O) catalyst, sodium carbonate as a base and DME 
or 1,4-dioxane as solvent.46 So applying a method from the literature we tried the 
coupling reaction using the previously synthesised 4-benzyloxyphenylboronic acid 131 
and the iodo compound 127 (Scheme 48). 
OBn 
~ 
# + 
/B" 
HO OH 
131 127 
----~.. No Observed Product 
o 
Scheme 48. 
N~C03' 
1,4-Dioxane 
After work up of the reaction, TLC of the crude material showed 4 spots very close 
together (two of which were the starting materials, 127 and 131). Unfortunately after 
three successive chromatography columns the 4 spots were unable to be separated. It was 
found out later that it is extremely hard to purify this product because the product, 
boronic acid and iodo compound have almost identical Rr values. The reaction was 
repeated with the same reagents and conditions and although the product did appear to be 
present by IH NMR spectroscopy (there was a methyl signal at /) 2.82, which was not that 
of the iodo compound 127 or the dehalogenated material 73) purification was proving 
difficult. We therefore decided to try this reaction using the same conditions with 4-
hydroxyphenylboronic acid (which was purchased), to give a product which should be 
80 
more polar (due to the unprotected hydroxy group) and thus have a different Rr value and 
be easier to purify (Scheme 49). 
OH 
H ~ ~ N-O N-O I r ~ {f" # + {f" Pd(PPh3)4 
• 49% 
Na2C03• 
/B" 0 1 ,4-Dioxane N 0 H 
HO OH 
131 127 132 
Scheme 49. 
This time the reaction proved successful, with the coupled product 132 isolated in 49% 
yield, and purification was easier with clear separation between the very polar product 
and the starting materials. 
We believed however, that the unprotected hydroxy group would interfere with any anion 
chemistry conducted on the C-3 methyl group so we therefore briefly looked at protecting 
this with the benzyl group using benzyl bromide (I eq.) and a weak base potassium 
carbonate (1 eq.) but this failed after heating to reflux overnight yielding only starting 
material (Scheme 50). The pKa of 2-pyridones is slightly less than that of phenol (17 to 
18 in DMSO) so this could lead to both the amide and the hydroxy group potentially 
being deprotonated and hence interfering with reaction. The reaction may work using 
more benzyl bromide but it possible that both the nitrogen and hydroxy groups may react 
with the benzyl bromide. 
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Scheme 50. 
We believed that in order to conduct any reaction at the C-3 methyl group we would first 
need the protected para-hydroxyphenyl group on the left hand portion of the molecule. 
we therefore set about re-examining coupling with 4-benzyloxyphenylboronic acid. It 
was found that the coupling reaction was successful but purification was proving 
difficult. To confirm that we had made the right product we took the unseparated mixture 
and treated it with molybdenum hexacarbonyl; this changed the polarity of the product 
and enabled easier purification to give the enaminone 134 (Scheme 51). 
BnO ~ BnO ~ NH2 0 
~ MO(CO)6. MeeN ~ ~ 
• 
N 
H 
133 134 
Scheme 51. 
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After numerous attempts at purification of the Suzuki product, it was found that by 
triturating the mixture in 2% methanol and filtering the remaining solid the desired 
product 133 could be obtained in pure form in 42% yield. 
Attempts to repeat this reaction were proved inconsistent, and we believed this was due 
to the quality of the catalyst. Palladium tetrakis(triphenylphosphine) is a very air-
sensitive catalyst and tends to degrade quite quickly. We tried purchasing the catalyst 
from various suppliers and also borrowed from another research group in Loughborough, 
a sample which was made in our laboratories but again the results were inconsistent. It is 
believed that not only is the ootalyst possibly degrading but that there are catalyst poisons 
present in the starting materials making the reaction fail or give very low yields (13 & 
8%). 
We therefore set about finding another procedure which would be more reliable. 
Searching through the literature we found a method which used a source of palladium(II) 
as a catalyst, palladium acetate. This is an a air stable catalyst and the reactive 
palladium(O) species is generated in situ on reaction with triphenylphosphine.47 The 
method was first tried on a small scale, heating at reflux in DMF for 2.5 h using 3 mol% 
catalyst and triethylamine as a base (Scheme 52). Analysis of the resultant crude mixture 
by IH NMR spectroscopy revealed that C-3 methyl signal of the product 133 was present. 
OBn 
BnO ~ N-
~ ~ 
+ Pd(OAch. 2 eq. PPh3 
• 
NEt3 
/B"" N 0 H 
HO OH 
127 
131 133 
Scheme 52. 
The reaction was repeated with reaction times of 8 h and 24 h and a yield of around 20-
25% was obtained. Although the reaction was successful purification was again proving 
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difficult so we decided to look at other methods. We found a paper by FU48 in which he 
has attempted to develop a general protocol for the Suzuki cross coupling reaction (given 
that there are many differing methods reported) which would work in the majority of 
cases and be independent of the structure of the reactants. After a lot of experimentation 
he came up with the conditions shown in Scheme 53 which we decided to replicate. 
OBn 
Bn ~ ~ N-O 
r ~ ~ + Pd2(dbah (2.5%) 
• 
P(t-Buh (6%) 
Hc!'OH 
0 
KF 
127 
131 133 
Scheme 53. 
This used palladiumbisbenzylideneacetone as an air-stable source of palladium(O) with 
tri-tert-butylphosphine as ligand (which is more effective than triphenylphosphine for 
palladium cross coupling reactions due to the increased electron donating effect) and 
potassium fluoride (which has been shown to act in the same capacity as a base in the 
Suzuki reaction due to its high affinity for boron).49 Using 2.5 mol% catalyst we 
proceeded with the reaction using Fu's conditions, stirring overnight at room 
temperature. Analysis by TLC the next day revealed no product was present (the coupled 
product is extremely fluorescent by TLC due to the high degree of conjugation present in 
the molecule), so the reaction was therefore left for a further 3 days but again TLC 
analysis revealed no product was present. In a last attempt to get the reaction to work the 
mixture was heated to reflux and left on overnight but again there was no evidence of any 
product by TLC and also in the crude IH NMR spectrum. Given that in Fu's paper, of the 
numerous examples he reports all were successful to some degree even those which used 
aryl or vinyl chlorides (which are not very reactive in the Suzuki reaction), we were 
puzzled by this result, so we decided to return to the palladium(lI) source, palladium 
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acetate which had so far worked on every occasion. Due to the low yield obtained 
previously and again the difficulty in purification it was decided to try the same method 
but with a range of ligands: triphenylphosphine, tricyclohexylphosphine, tri-tert-
butylphosphine (Table 2) and also with a reusable solid phase catalyst source using DMF 
as a solvent. The solid phase catalyst source has the palladium acetate and 
triphenylphosphine adsorbed onto a polyurea matrix (contains 0.4 mmol Pdlg ofpolyurea 
and 1/0.8 mmol PdJPPh3).50 The catalyst can reportedly be filtered off and reused up to 
six times before any activity is lost. 
Base Catalyst Ligand Temp (0C) Time (b) Result 
NEt3 Pd(OAc)2 PPh3 75 18 SM 
NEt3 Pd(OAch peY3 75 18 SM 
NEt3 Pd(OAc)2 P'BU3 75 18 SM+73 
NEt3 Solid Phase - 100 3 SM+73 
Table 2. 
Looking at Table 2 the results were very disappointing. Using triphenylphosphine and 
tricyclohexylphosphine on this occasion resulted only in starting material as detected by 
crude IH NMR spectroscopy. Using tri-tert-butylphosphine as a ligand, starting material 
127 and a small amount of the dehalogenated product 73 were obtained, however on 
using the solid phase catalyst the boronic acid 131, iodo compound 127 and the 
dehalogenated compound 73 were obtained roughly in the ratio 1:1:2. This suggests that 
the palladium must be inserting into the aryl-halogen bond but that the transmetallation 
process must not be working effectively. This led us to examine the effectiveness of the 
base triethylamine so other bases were investigated (Table 3). 
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Base Catalyst Ligand Temp(OC) Time (h) Result 
K2C03/H20 Solid Phase - 100 3 SM 
K2C03/ H20 Solid Phase - 100 18 SM 
KF Solid Phase - 100 3 SM 
Table 3. 
The solid phase catalyst had given most of the dehalogenated product 73 rather than 
starting material so we used this on each occasion as catalyst and again DMF as the 
solvent with potassium carbonate and potassium fluoride as the bases. Unfortunately the 
results were again very disappointing with on this occasion only starting material 127 
isolated and no evidence of any of the dehalogenated product in the crude IH NMR 
spectra. There was also a loss of material which may have decomposed or been lost in 
the work up. 
A slightly different method to that previously used was found in a paper by Smith et al. 
which examined the mechanism of the Suzuki reaction.43 They proposed firstly that the 
base used should have a pKa close that of the boronic acid (benzeneboronic acid has pKa 
8.8 so carbonate pKa 10.3 is suitable) in order to form the boronate complex which is 
then capable of effecting transmetallation (Scheme 54). They then reasoned that two 
equivalents of base and water are needed, one to form the boronate complex and the other 
to neutralize boric acid, the coupling reaction byproduct. 
Scheme 54. 
Applying the theoretical principles to practice this paper reported some very reliable 
results so we decided to use the same method (Table 4) using only 1 mol% catalyst and 
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DME as solvent but again unfortunately after heating at reflux overnight no product was 
observed by TLC. So at this stage we were becoming very frustrated and wondering why 
this chemistry was not working, so instead of using 1 mol% catalyst it was decided to use 
50 mol% just to see if any product would be obtained. After refluxing for two hours TLC 
showed the product to be present and analysis of the crude lH NMR spectrum confirmed 
the presence of the coupled product in around 20% yield. The reaction was repeated for 
around 5 h and a yield of around 39% was obtained (Table 4). The same article also 
talked about catalyst poisons and showed by experimentation that since the catalyst used 
was in a small amount relative to the reactants, small impurities present in the reactants 
retarded the coupling significantly and we believe this is the most likely cause for the 
unpredictability of the reaction in our case. 
Base CatalystiLigand Mol% Temp (0C) Time (h) Yield (%) 
K2C0 3/H20 Pd(OAc)2/ PPh3 1 90 18 0 
K2C03/H2O Pd(OAch/ PPh3 50 90 2 20 
K2C03/ H20 Pd(OAc)2/ PPh3 50 90 5 39 
Table 4. 
Although the reaction was working in each instance purification was again proving 
difficult. Column chromatography again failed to separate the product from the starting 
materials and the best method found so far for purification, trituration of the product in 
2% methanollDCM, did not work in this instance due to the large amount of catalyst 
present although it was possible on chromatographed material. 50 mol% Catalyst is a lot 
so we looked at reducing this significantly. With project time running out we decided to 
employ 20 mol%, firstly trying with the unprotected 4-hydroxybenzeneboronic acid 
where the product is easier to purify, and this led to a 36% yield of the coupled product 
132. Repeating this procedure using 2M potassium carbonate as opposed to using 
stoichiometric quantities of water produced a similar yield of around 40%. The process 
was then repeated with the 4-benzyloxybenzeneboronic acid and after trituration a yield 
of 30% of the coupled product 133 was obtained as a very clean sample. So after a great 
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deal of experimentation a reliable method for Suzuki coupling had been developed and 
although the yield was moderate, time was running out as we looked to progress to the 
natural product tenellin 2 and the results therefore satisfied our requirements, although it 
is very likely that this yield can still be further increased with more experimentation. 
Finally because we intended to take this product 133 and couple it with E-2,4-
dimethylhex-2-enaI30 which would lead towards a natural product, an attempt was made 
to repeat the coupling reaction with another protected boronic acid, 4-
methoxybenzeneboronic acid 134 (which is commercially available). This would lead to 
another compound which we could potentially couple with 30 and progress towards our 
target natural product. The reaction was successful using exactly the same conditions, 
giving the coupled product 135 in around 14% yield (Scheme 55) which is slightly 
disappointing but the reaction was only attempted on one occasion. 
OM. 
Me ~ ~ 
+ f? ~ Pd(OAc)2 (20%) 
• 
PPh) (40%) 
HcI'-OH N 0 H 2MK2CO) 
127 
134 135 
Scheme 55. 
2.8 N-Oxidation 
Having developed methods for elaborating at the C-3 and C-7 positions of 
isoxazolopyridone 73, we needed to looked at a method for oxidation of the amide 
nitrogen as some of the natural products, contain an N-OH bond including tenellin 2 
towards which we are hoping to progress. It has been shown that the trimethylsilylation 
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of secondary amides activates them towards oxidation to hydroxamic acids.sl Pyridones 
such as 73 will be O-siIylated as opposed to N-silylated and to oxidize trimethylsiIylated 
amides aprotic oxidants are required. One such oxidant is the peroxo-molybdenum 
complex MoOPH which was used by Rigby in the total synthesis of teneJlin 2.52 
Although this oxidant has been successful in the oxidation of secondary amides we 
decided to use a safer alternative known as MoOPD which uses DMPU to complex to the 
molybdenum as opposed to the possible carcinogen HMPA.s3 
2.8.1 Synthesis of MoOPD' 
Molybdenum (VI) oxide was oxidized with aqueous hydrogen peroxide (Scheme 56) and 
then treated with DMPU to give 136 which was obtained on recrystallisation from 
methanol. 
2.DMPU 
Scheme 56. 
In order to form MoOPD the water must be removed from complex 136 and the 
molybdenum complex then treated with pyridine. In order to dehydrate 136 a vacuum of 
at least 0.5 mmlHg for 24 h is required over phosphorus pentoxide, and since the 
complex decomposes above 40°C heating can be used up to 35°C. After dehydration 
treatment with one equivalent of pyridine in THF gave MoOPD 137 (Scheme 57) as fine 
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yellow crystals. The IR data were identical with that published in the literature. The 
complex is stable if stored in the fridge with a drying agent and protected from light. 
136 137 
Scheme 57. 
2.8.2 Silylation and Oxidation of 73 
The isoxazolopyridone 73 and an excess of hexamethyldisilazane containing a few drops 
oftrimethylsilyl chloride were heated at reflux in DCM for 8 h (Scheme 58). The DCM 
and hexamethyldisilazane were then removed under vacuum and the crude product 
analysed by IH NMR spectroscopy. The IH NMR spectrum showed a large peak around 
/) 0.06 which would correspond to a trimethysilyl group and also the doublets which 
correspond to the hydrogens of C-6 and C-7 had shifted. Despite not being certain that 
silylation had taken place, and assuming that this molecule would be quite unstable, we 
decided to proceed and treat the residue with MoOPD 137 using 2 eq. stirring in DCM at 
room temperature overnight. 
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Scheme 58. 
After removal of the solvent the residue was subjected to column chromatography. The 
TLC showed two clear spots, the first spot to come off the column was that of the starting 
material as confmned by its 1 H NMR spectrum. The second spot to come off the column 
looked to be that of the desired product complexed to the MoOPD as DMPU was present 
in the IH NMR spectrum. To remove the molybdenum complex the material was treated 
with saturated aqueous EDT A solution, stirring vigorously for two hours and repeating 
the process 3-4 times until all of the DMPU was removed as seen by IH NMR 
spectrocopy. Due to the similarities of starting material and product, mass spectrometry 
would be the easiest way to determine if the product was formed, however quite 
fortuitously we managed to obtain some very nice crystals of the supposed product and 
therefore submitted them for X-ray analysis (X-Ray 2). Unfortunately as can be seen 
from the X-ray crystal structure the very nice crystals turned out to be starting material 73 
and we can assume that the molybdenum was merely complexing to the starting material. 
The reaction will need to be repeated, perhaps using another method for silylation and 
ensuring that silylation has worked and the pyridine formed, otherwise N-oxidation will 
not take place. 
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2.9 Natural Product Synthesis 
Having developed methods for elaborating at the C-3 methyl group and the C-7 position 
of 73, our next objective became to progress towards the natural product tenellin 2 
(Scheme 59). Even though we have not yet successfully N-oxidised the 
isoxazolopyridone system, there is precedent for this in other natural product syntheses.24 
If we take the Suzuki coupling product 133 and apply the anion chemistry we have 
developed to couple it with E-2,4-dimethylhex-2-enal 30, this will lead to the tenellin 
precursor 138. Dehydration with for example para-toluenesulfonic acid will lead to the 
dehydrated material 139, and finally removal of the benzyl group with boron tribromide 
followed by isoxazole ring opening and diazotization (or vice versa, i.e. ring opening and 
diazotization before debenzylation) will lead to 140. Compound 140 has been made 
previously by Rigby and was treated with MoOPH to oxidize the amide to the 
hydroximic acid to yield racemic tenellin 2.24 
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Synthesis of 140 would thus constitute a fonnal synthesis of 2. Before trying to couple 
133 with E-2,4-dimethylhex-2-enal 30 we decided to try a test reaction with 
crotonaldehyde (Scheme 60) which is commercially available, and also because at the 
time we only had a very small amount (16 mg) of the Suzuki coupled product 133. 
Despite the small mass used, after chromatography and recrystallisation, we were able to 
isolate about 8 mg of the hydroxy adduct 141 which equates to 37% yield. 
BoO 
o 
+ H~ 
N o 
H 
133 ! 2.2 eq n-BuLi -78°C 
BoO 
37% 
o 
141 
Scheme 60. 
Having made more of the benzyl protected Suzuki product 133 we next tried to couple it 
with E-2,4-dimethylhex-2-enal 30 (Scheme 61). Using the same reaction conditions 
analysis of the crude material by TLC showed 6-7 spots with very similar RF values, and 
the crude material was therefore subjected to chromatography using DCM and methanol, 
however the separation was still poor with all the spots co-eluting. The material was 
chromatographed again but still there was no separation of the spots. Analysis of the 
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material by IH NMR spectroscopy did however appear to show the presence of the 
desired product but was inconclusive. 
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H 
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Scheme 61. 
The product contains two diastereotopic CH2 groups making the IH NMR relativel 
complex so an attempt was made to dehydrate the material (Scheme 62), on this occasion 
using hydrogen bromide in acetic acid in an attempt to simultaneously remove the benzyl 
group but this only led to decomposition of the starting material. After repeating the 
reaction a few more times a small amount of the product was obtained after 
chromatography and recrystallisation. Due to the small amount isolated only a IH NMR 
spectrum was recorded, which shows what appears to be the desired product 138 and also 
a small amount of the starting material 133; no yield could be recorded. There is no 
reason to suppose that this reaction will not work and it needs to be optimised whilst also 
possibly trying to couple the aldehyde 30 with the methyl protected Suzuki coupling 
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product 135. Unfortunately at this point we ran out of time and material so no further 
studies could be undertaken. 
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Scheme 62. 
2.10 Conclusion and Future Work 
A revised method for synthesising the latent 3-acyl-4-hydroxypyridin-2-one core 73 has 
been developed which uses isoxazoles to mask the tricarbonyl grouping. A method for 
elaborating at the C-3 methyl position of isoxazolopyridone 73 with range of aldehydes 
has been developed, including with E-2,4-dimethylhex-2-enal 30, the aldehyde that 
would lead to the natural product tenellin 2. A method for incorporating into 73 the 
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para-hydroxyphenyl grouping present in the majority of these natural products has also 
been developed which involves using the Suzuki coupling reaction. Progress towards the 
natural product tenellin 2 has been made which involves elaborating at the C-7 position 
of core building block 73 using the Suzuki reaction and then taking the coupled product 
and applying the anion chemistry developed for elaborating at the C-3 methyl group and 
reacting with the appropriate aldehyde. If this is successful 3-4 more steps will lead to 
teneIIin 2. Future work will involve continuing to progress towards tenellin 2 using the 
methods developed so far and then apply the methodology towards other natural products 
which contain the 3-acyl-4-hydroxypyridin-2-one core. 
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Chapter 3 Experimental 
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General Details 
IH NMR spectra were measured at 250 MHz or at 400 MHz using a Bruker AC 250 
spectrometer or a Bruker DPX 400 MHz spectrometer. Chemical shift, 15, values are given in 
ppm (parts per million) and coupling constants in hertz. 
Multiplets are denoted by the following symbols: s, singlet; d, doublet; t, triplet; q, quartet 
and m, multiplet. 
13C NMR spectra were recorded on a Bruker AC 250 MHz or a Bruker DPX 400 MHz 
instrument operating at 62.86 and 100.62 MHz respectively. 
All spectra were recorded using tetramethylsilane (TMS) as the internal reference in CDCb or 
rl6-DMSO as solvent. 
m spectra were determined using a Perkin Elmer FT-IR Paragon 1000 spectrometer. 
All the infrared spectra were recorded in the range 4000-600 cm· l . 
Mass spectra were recorded on a Jeol SX 102 instrument or by using the ESPRC National 
Mass Spectrometry Service Centre. In the description of mass spectra [M+W], [M+NH/] 
and ~ refer to the molecular ion peak obtained by ionization. The intensity of principle 
peaks (m/z) are given as a percentage relative to the base peak. 
Microanalyses were performed on a Perkin Elmer Analyser 2400 CHN. Results are given as 
a percentage composition. 
Melting points were determined using an Electrothermal-IA 9100 and are uncorrected. They 
are given in degrees Celsius eC). 
Thin Layer Chromatography using silica gel as the absorbent was carried out with 
aluminium backed plates with silica gel (Merck Kieselgel60 F254). 
(visualization method?) 
Column Chromatography using silica gel was carried out with Merck Kieselgel 60 H silica. 
Solvents were distilled before use. Petroleum ether (b.p. 40-60°C) and ethyl acetate were 
distilled from calcium chloride. Dichloromethane (DCM) was distilled from calcium 
hydride. Tetrahydrofuran (THF) was freshly distilled from sodium and benzophenone under 
an atmosphere of nitrogen. Methanol was freshly distilled from magnesium hydroxide. 
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Methyl 2,3-diaminopropanoate dihydrochloride 9254 
To a stirred suspension of2,3-diaminopropanoic acid hydrochloride (6.20 g, 44.11 nunol) in 
dry methanol (100 ml) was added freshly distilled acetyl chloride (70.00 g, 900.00 mmol) 
dropwise at 0 °C. The mixture was allowed to warm to room temperature and then heated 
under reflux for 4 days. After this time the precipitate was filtered and dried and the material 
treated with fresh methanol and acetyl chloride under the same conditions for a further 2 days 
and the mixture filtered to yield the title compound 92 (7.12 g, 85%) as a white solid; 
decomposes 189 °C, 1l1l(250 MHz; [CD3]zSO) 3.34 (2 H, d, J 6.0, CHCH2), 3.78 (3 H, s, 
CH3), 4.46 (I H, t, J 6.0, CH2CH) & 8.93 (6 H, br s, 2 x NH3); Ilc(IOO MHz; [CD3]2S0) 38.2 
(CH3), 50.0 (CH2), 53.3 (CH) & 166.9 (C). 
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2,3-Bis(tert-butyloxycarbonylamino)propionic acid methyl ester 93 
To methyl 2,3-diaminopropanoate dihydrochloride 92 (2.0 g, 10.47 mmol) in 
dichloromethane (100 ml) were added di-tert-butyl dicarbonate (4.8 g, 21.99 mmol) and 
triethylamine (4.2 g, 41.88 mmol) at 0 °C. The reaction mixture was stirred for 18 h. The 
reaction mixture was then washed with citric acid solution (IM, 2 x 150 ml), saturated 
sodium hydrogen carbonate solution (150 ml), saturated brine (2 x 150 ml) then dried and 
evaporated under reduced pressure to yield the title compound 93 (3.0 g, 90%) as a white 
solid; mp 82-84 °C (from DCM); vmax(DCM)!cm·t 3372,2977, 1754, 1716, 1698, 1519, 
1392, 1367, 1165, 1074 & 845; (Found: C, 52.5; H, 8.1; N, 8.55. C14H26N206 requires C, 
52.8; H, 8.2; N, 8.8%); IiH(250 MHz; CDCh) 1.43 (18 H, s 2 x QCH3]3), 3.51-3.54 (2 H. m. 
CHCH2), 3.76 (3 H, s, CH3), & 4.33 (l H, br s, CH2CH); Iic(100 MHz; CDCh) 27.1 (CH3), 
28.2 (CH3), 42.3 (CH2). 52.5 (CH3). 54.2 (CH). 79.7 (C). 80.0 (C). 155.4 (C). 156.2 (C) & 
171.3 (C); mlz (ES) 319.1862 ([M+Ht. Ct4H27N206 requires 319.1864). (El) 263 (17). 
219(8).207 (100%).189 (7).145 (27), J33 (40),101 (23),85 (57) & 57 (100). 
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2,3.Bis(tert·Butyloxycarbonylamino)propanaldehyde oxime 95 
"""N)CO'C", ____ ....... ~ 
BocHN 
BocHN 
BocHN 
Preparation of the aldehyde 
DIBAL·H (1.0 M in toluene, 110 ml, 110.77 mmol) was added (dropwise over 35 min) to a 
stirred solution of93 (9.30 g, 29.25 mmol) in toluene (225 ml) at ·78 °C. The mixture was 
stirred for a further 65 min and methanol (20 ml) was then added. The mixture was poured 
into a solution of potassium sodium tartrate (250 g) in water (500 ml) and stirred vigorously 
for 1.5 h. The aqueous phase was separated and extracted with ethyl acetate (2 x 300 ml). 
The organic phases were combined, washed with brine (2 x 300 ml), dried and concentrated 
to give the aldehyde 94, which was used immediately to form the oxime. 
Preparation of the oxime 
To hydroxylamine hydrochloride (3.07 g, 58.50 mmol) and sodium acetate (9.60 g, 177 
mmol) in water (60 ml) was added the crude aldehyde in ethanol (15 ml). The reaction 
mixture was warmed to 70°C for 10-15 mins, cooled and stored in a refrigerator overnight. 
The white precipitate was filtered, washed with water (75 ml) and dried to give the title 
compound 95 (7.5 g, 85%) as a white solid; vmax(DCM)!cm-1 3342, 2977, 2932, 2358, 1693, 
1519, 1455, 1393, 1367, 1251, 1168 & 945; 13H(250 MHz; [CD3hSO) (anti isomer) 1.36 (18 
H, s, 2 x qCH3]3), 2.95-3.14 (2 H, m, CHCH2), 4.07-4.18 (I H, m, CH2CH) & 7.11 (1 H, d, J 
6.0, CHCHN), (syn isomer) 1.37 (18 H, s, 2 x qCH3]3), 3.24-3.38 (2 H, m, CHCH2), 4_61-
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4.75 (1 H, m, CH2CH) & 6.50 (I H, d, J6.0, CHCHN);oc(IOO MHz; CDCh) (anti isomer) 
28.1 (CH3), 42.0 (CH2), 50.0 (CH), 148.2 (CH), 155.6 (C) & 170.3 (C), (syn isomer) 28.1 
(CH3), 46.4 (CH), 61.2 (CH2), 149.4 (CH), 154.8 (C) & 172.0 (C); m/z (El) 303.1790 (M+, 
C13H2SN30s requires 303.1794), 41 (19%),57 (100), 73 (11), 85 (3), 101 (20), 118 (97), 130 
(9),156 (3),174 (30), 191 (38),247 (7) & 303 (1). 
Ethyl 3-(1-pyrrolidino)-2-butenoate 8655 
Ethyl acetoacetate (21.75 g, 167.13 rnmol) and pyrrolidine (13.55 g, 190.52 rnmol) were 
heated together in toluene (300 ml) at reflux under Dean-Stark conditions. After 4 h the 
mixture was cooled and the solvent evaporated under reduced pressure to yield the title 
compound 86 (30.06 g) as a yellow brown oil that was not further purified; vrnax(filrn)/crn·1 
2973,2867,2856,1676,1576,1430,1344,1137,1057 & 787; oH(250 MHz; CDCh) 1.25 (3 
H, t, J 7.0, CH2CH3), 1.90-1.94 (8 H, rn, NCH2CH2), 2.47 (3 H, s, CH3), 4.10 (2 H, q, J7.0, 
CH3 CH2) & 4.46 (!H, S, COCH). 
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Ethyl 3-[1 ,2-bis(terl-butoxycarbonylamino)ethyl)-5-methylisoxazole-4-
carboxylate 90 
BocHN BocHN 
H 
BocHN BocHN 
A solution of 2,3-bis(terl-butyloxycarbonylamino)propanaldehyde oxime 95 (10.00 g, 33 
mmol) in chloroform (500 ml) was treated with NCS (4.85 g, 36.30 mmol) and the mixture 
heated to reflux for 2 h and then more NCS (4.85 g, 36.30 mmol) added. The reaction 
mixture was then heated at reflux overnight. A solution of ethyl 3-(l-pyrrolidino )-2-
butenoate 86 (22.69 g, 123.86 mmol) in chloroform (30 ml) was then added in one portion, 
followed by triethylamine (5.44 g, 53.73 mmol) dropwise over 2 h. The mixture was heated 
at reflux for 3 h. The solution was cooled and washed with citric acid solution (2 x 500 ml), 
saturated sodium hydrogen carbonate solution (500 ml), brine (500 ml), dried and 
concentrated. The resulting crude oil was purified by column chromatography on silica using 
light petroleum / ethyl actetate (4:1, v/v) as eluent to leave the title compound 90 (7.00 g, 
53%) as a clear yellow oil; vmax(CDCh)/cm,1 3368,2975,2251, 1734, 1700, 1696, 1684, 
1675, 1603,1507, 1363 & 1260; SH(250 MHz; CDCh) 1.39 (9 H, s, QCH3h), 1.41 (3 H, t, J 
7.0, CH2CH3), 1.44 (9 H, s, QCH3h), 2.66 (3 H, s, 5-CH3), 3.55 (2 H, t, J 6.0, CHCH2), 4.35 
(2 H, m, CH3CH2) 5.04 (1 H, br, NIl), 5.30 (l H, br, NHCH2CH) & 5.94 (I H, br, NIl); 
Sc(100 MHz; CDCh) 13.5 (CH3), 14.2 (CH3), 28.2 (CH3), 28.3 (CH3), 43.5 (CH2), 48.6 (CH), 
61.22 (CH2), 79.4 (C), 79.9 (C), 108.0 (C), 155.4 (C), 156.0 (C), 161.4 (C), 162.0 (C) & 
176.0 (C); m/z (ES) 414.2236 ([M+Ht, CI9H32N307 requires 414.2235), (El) 401 (9), 358 
(13),327 (18), 314 (88), 302 (100%), 296 (75), 155 (20), 137 (12), 57 (100) & 41 (78). 
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Ethyl 3-(1,2-diaminoethyl)-5-methylisoxazole-4-carboxylate 
dihydrochloride 99 
N-O 
BocHN r # C1H3N 
• 
C02Et 
BocHN C1H3N 
N-O 
r # 
C02Et 
Trifluoroacetic acid (52 ml) was added to a stirred solution of ethyl 3-[1,2-bis(tert-
butoxycarbonylamino)ethyIJ-5-methyIisoxazole-4-carboxylate 90 (2.8 g, 7.0 mmol) at 20°C 
and the reaction was stirred for 4.5 h and evaporated to dryness. Hydrochloric acid (2M, 100 
ml) was added and the reaction stirred for 0.5 h and evaporated to dryness. The residue was 
dissolved in water (200 ml), washed with ethyl acetate (2 x 200 ml) and evaporated to give 
the title compound 99 (1.9 I g, 99 %) which was used without further purification. 
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3.Methyl.5H.isoxazolo[4,3-c]pyridin-4-one 7355 
N-O N-O N-O 
CIH3N ~.# H,N ~# ~# 
• • 
CO,Et 
C1H3N N 0 N 0 H H 
Method A 
Sodium carbonate (3.32 g, 31.32 mmol) was added to a solution of ethyl 3·(I,2-diamino-
ethyl)-5-methylisoxazole-4-carboxylate dihydrochloride 99 (3.8 g, 13.29 mmol) in water (170 
ml) at 20°C and the reaction stirred overnight and then concentrated under reduced pressure. 
The aqueous layer was then extracted with dichloromethane (8 x 100 ml) and the 
dichloromethane extracts combined, dried and evaporated under reduced pressure to give 7-
amino-3-methyl-4,5,6,7-tetrahydroisoxazolo[4,3-c]pyridin-4·one 101 (1.6 g, 72%) as a pale 
yellow solid that was used without further purification; decomposes 140°C (from 
dichloromethane); (5H(250 MHz; [CD3hSO) 2.64 (3H, s, 3-CH3), 3.59 (HI, ddd, J = 13.0, 6.0 
& 5.0 Hz, CHCH1), 3.71 (!H, ddd, J= 13.0,5.0 & 2.5 Hz, CHCH2), 4.74 (!H, dd, J= 6.0 & 
5.0 Hz, CHCH2) & 8.02 (!H, br); (5c(lOO MHZ; [CD3hSO) 11.7 (CH3), 41.2 (CH), 43.8 
(CH2), 107.4 (C), 159.3 (C), 160.9 (C) & 172.0 (C). 
Hydrochloric acid (2M, 90 ml) and sodium nitrite (I g, 14.49 mmol) in water (16 ml) were 
then added to a solution of amine 101 (1.6 g, 9.58 mmol) at 0 °C and the mixture stirred for 1 
h, and then for 1 h at 50°C. The mixture was then extracted with dichloromethane (3 x 
100ml). The combined organic phases were dried and evaporated to give the title compound 
73 (1.2 g, 84%) as pale yellow solid; mp 206°C (from dichloromethane) (lit.mp.,55 206°C); 
(5H(250 MHz; CDCh) 2.87 (3 H, s, 3-CH3), 6.40 (1 H, d, J 7.5, NHCHCH), 6.98 (1 H, dd, J 
7.5 & 6.0, NHCH) & 9.27 (!H, br, NH); (5c(lOO MHz; CDCh) 13.1 (CH3), 95.1 (CH), 108.6 
(C), 132.9 (CH), 158.3 (C), 161.1 (C) & 174.1 (C). 
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Method B Experimental 
Sodium carbonate (1.57 g, 14.83 mmol) was added to a solution of ethyl 3-(1,2-diamino-
ethyl)-5-methylisoxazole-4-carboxylate dihydrochloride 99 (1.80 g, 6.29 mmol) in water (100 
ml) at 20°C and the reaction stirred overnight and then concentrated under reduced pressure. 
Hydrochloric acid (2M, 20 ml) and sodium nitrite (429 mg, 6.23 mmol) in water (20 ml) were 
then added to the solution at 0 °C and the mixture stirred for I h, and then for I h at 50°C. 
The mixture was then extracted with dichloromethane (3 x 100 ml). The organic phase was 
separated, dried and evaporated to give the title compound 73 (71 %, 0.67 g) as a pale yellow 
solid, data identical to material from method A. 
7 -lodo-3-methyl-5H-isoxazolo[4,3-c]pyridin-4-one 12755 
N 
H o 
Iodine monochloride (1.0M, 1.5 ml) was added to a solution of 3-methyl-5H-isoxazolo[4,3-
cJpyridine-4-one 73 (150 mg, 1 mmol) in dichloromethane (10 ml) at 20°C and the reaction 
was stirred for 72 h. The crystalline solid was filtered and washed with dichloromethane (l0 
ml) to give the title compound 127 (177 mg, 64%) as a pale purple solid; mp 214-217 °C 
(from dichloromethane) (lit.mp.,55 218°C); oH(250 MHz; [CD3hSO) 2.77 (3 H, s, 3-CH3), 
7.44 (1 H, d, J 6.0, NHCH) & 11.06 (l H, br, s, Nil); oc(100 MHz; [CD3]2S0) 12.9 (CH3), 
51.6 (CH), 107.4 (C), 140.3 (C), 158.9 (C), 159.0 (C) & 175.1 (C). 
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4.Benzyloxybromobenzene 12944 
OH OBn 
.. 
Br Br 
Potassium carbonate (3.59 g, 26.01 mmol) was added to a solution of 4-bromophenol128 
(3.00 g, 17.34 mmol) and benzyl bromide (2.97 g, 17.34 mmol) in acetone (150 ml) and the 
reaction mixture heated under reflux for 24 h. After cooling the solvent was evaporated and 
the residue dissolved in ethyl acetate (200 ml), washed with sodium hydroxide solution (IM, 
3 x 100 ml), brine (lOO ml), dried and evaporated under reduced pressure to give the title 
compound 129 (3.84 g, 84%) as a white solid; mp 63°C (from hexane) (lilmp.,56 63°C); 
oH(250 MHz; CDCh) 5.01 (2 H, s, CH2), 6.87 (2 H, d, J7.0, Ar-CH) and 7.33-7.45 (7 H, m, 
Ar-CH); oc(lOO MHz; [CD3hSO) 70.2 (CH2), 113.1 (CH), 116.7 (C), 127.4 (CH), 127.7 
(CH), 128.1 (CH), 132.6 (CH), 136.5 (C) & 157.8 (C). 
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4-Benzyloxyphenylboronic acid 131 45 
OBn OBn 
.. 
Br 
n-Butyllithium (1.7 ml of a 2.5M solution in hexanes, 4.2 mmol) was added dropwise over a 
period of 10 min at -78°C under nitrogen to a solution of 4-benzyloxybromobenzene 129 (\ 
g, 3.8 mmol) in tetrahydrofuran (20 ml). The mixture was stirred for 30 min and then 
triisopropyl borate (2.6 ml, 11.4 mmol) was added and the mixture stirred for 10 min. The 
mixture was allowed to warm to 0 °C and water added (1.5 ml). The mixture was stirred at 
room temperature for 18 h and extracted with ethyl acetate (2 x 50 ml) and the extract washed 
with water (50 ml), brine (50 ml), dried and concentrated under reduced pressure. The 
resulting solid was washed with hexane to give the title compound 131 (0.77 g, 88%) as a 
pale yellow solid; mp \90-\92 °C (from ethyl acetate) (Iit.mp.,s9 189-193 °C); OH (250 MHz; 
CDCh) 5.15 (2 H, s, CH2), 7.01 (2 H, d, J9.0, Ar-CH), 7.34-7.49 (5 H, m, Ar-CH) & 8.15 (2 
H, d, J 9.0, Ar-CH); oe (100 MHz; CDCh) 69.9 (CH2), 113.8 (CH), \ 13.9 (C), 127.7 (CH), 
127.8 (CH), 128.4 (CH), 135.8 (CH), 137.0 (CH) & \ 60.0 (C). 
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7 -(4-Hydroxyphenyl)-3-methyl-5H-isoxazolo[4,3-c]pyridin-4-one 132 
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To a suspension oftetrakis(triphenylphosphine)palladium (12 mg, 0.011 mmol) in anhydrous 
dioxane (10 ml) was added 7-iodo-3-methyl-5H-isoxazolo[4,3-c]pyridin-4-one 127 (100 mg, 
0.36 mmol) and the mixture stirred for 10 min at room temperature. To this solution were 
added sequentially 4-hydroxyphenylboronic acid (75 mg, 0.54 mmol) in ethanol (10 ml), and 
aqueous sodium carbonate (2M, 0.36 ml, 0.72 mmol) and the mixture was heated under 
reflux for 18 h and cooled. Water (50 ml) was added and the mixture extracted with 
dichloromethane (3 x 50 ml). The dichloromethane extracts were combined, washed with 
brine (50 ml), dried and evaporated to give a brown residue, which was purified by column 
chromatography on silica gel using dichloromethane / methanol (10:1, vlv) as eluent to leave 
the title compound 132 (41 mg, 49%) as a white solid; decomposes 250°C; vmax(DCM)/cm·J 
3723,2923,2851, 1699, 1653 & 1558; oH(250 MHz; [CD3hSO) 2.82 (3 H, s 3-CH3), 6.81 (2 
H, d, J 9.0, Ar-CH), 7.24 (I H, d, J 5.0, NHCH), 7.60 (2 H, d, J 9.0, Ar-CH) & (10.98 (I H, 
br, NH); /ic(100 MHz; [CD3hSO) 12.3 (CH3), 107.1 (C), 108.0 (C), 115.2 (CH), 124.2 (C), 
127.0 (CH), 130.4 (CH), 156.7 (C), 157.6 (C), 158.9 (C) & 173.6 (C); mlz (ES) 243.0765 
([M+Ht, C13HJON203 requires 243.0764), 227 (21),171 (22), 133 (11),118 (16), 84 (25), 49 
(43) & 43 (100%). 
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7 -(4-Benzyloxyphenyl)-3-methyl-5H-isoxazolo[4,3-c]pyridin-4-one 133 
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7-Iodo-3-methyl-5H-isoxazolo[4,3-c]pyridin-4-one 127 (400 mg, 1.45 mmol) and 4-
benzyloxyphenylboronic acid 131 (397 mg, 1.74 mmol) were added to dimethoxyethane (100 
ml) and the solution degassed and then purged with nitrogen. Palladium acetate (65 mg, 0.29 
mmol, 20 mol%), triphenylphosphine (152 mg, 0.58 mmol) and potassium carbonate solution 
(2M, 1.8 ml) were then added and the solution heated at reflux overnight. The 
dimethoxyethane was then removed under reduced pressure to leave a residue to which 
dichloromethane (50 ml) was added. The dichloromethane was washed with brine (50 ml), 
dried and evaporated under reduced pressure to leave a brown residue, which was trituated 
with dichloromethane / methanol (98:2, v/v) and filtered to leave the title compound 133 (144 
mg, 30%) as a white solid; decomposes 250 °C; vmax(KBr)/cm-J 3061, 2912, 1681, 1639, 
1518, 1359, 1252, 1175, 1043, 871 & 827; llH(250 MHz; [CD3hSO) 2.82 (3 H, s, 5-CHJ), 
5.14 (2 H, s, CH2), 7.07 (2 H, d, J 9.0, Ar-CH), 7.30-7.50 (6 H, m, Ar-CH), 7.73 (2 H, d, J 
9.0, Ar-CH) & 11.07 (1 H, brs, NH); llc(100 MHz; [CD3hSO) 12.4 (CH3), 69.1 (CH2), 106.6 
(C), 108.0 (C), 114.8 (CH), 126.1 (C), 127.7 (CH), 127.8 (CH), 128.0 (CH), 128.4 (CH), 
131.1 (CH), 137.0 (C), 157.5 (C), 159.1 (C) & 173.8 (C); mlz (ES) 333.1234 ([M+H]+' 
C2oH17N203 requires 333.1236), 332 ~), 299 (43), 277 (100%), 185 (18), 136 (17), 115 
(84), 100 (17) & 55 (14). 
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7 -(4-Methoxyphenyl)-3-methyl-5H-isoxazolo[4,3-cJpyridin-4-one 135 
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The same procedure as for the synthesis of 7-(4-benzyloxyphenyl)-3-methyl-5H-
isoxazolo[4,3-cJpyridin-4-one was used incorporating the following quantities: 7-iodo-3-
methyl-5H-isoxazolo[4,3-cJpyridin-4-one 127 (155 mg, 0.56 mmol), 4-
methoxyphenylboronic acid (102 mg, 0.80 mmol), potassium carbonate solution (2M, 0.7 
ml), dimethoxyethane (40 ml), palladium acetate (25 mg, 0.11 mmol) & triphenylphosphine 
(59 mg, 0.22 mmol) to give the title compound 135 (20 mg, 14%) as a white solid; 
decomposes 250°C; vmax(KBr)!cmOI 3452,2904,2344, 1683, 1646, 1506, 1359, 1297, 1247, 
1176 & 830; IiH(400 MHz; [CD3hSO) 2.84 (3 H, s, 5-CH3), 3.78 (3 H, s, OCH3), 7.00 (2 H, 
d, J 9.0, Ar-CIl), 7.33 (I H, d, J 6.0, NHCH), 7.74 (2 H, d, J 9.0, Ar-CH) & 11.05 (I H, br s, 
Nil); lie (100 MHz; [CD3hSO) 12.4 (CH3), 55.1 (CH3) , 106.7 (C), 108.0 (C), 114.0 (CH), 
131.4 (CH), 133.2 (C), 135.8 (CH), 158.5 (C), 159.0 (C), 160.9 (C) & 173.7 (C); mlz (ES) 
257.0923 ([M+Ht, CI4H13N203 requires 257.0921), (El) 256 (100%), 241 (24),213 (9),199 
(11), 185 (15), 171 (11), 147 (11), 132 (22), 77 (13), 63 (7), 51 (8) & 43 (73). 
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3-(2-Hydroxy-2-phenylethyl)-5H-isoxazolo[4,3-c]pyridin-4-one 104 
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Method A 
n-Butyllithium (0.9 ml of a 2.5M solution in hexanes, 2.18 mmol) was added to a solution of 
diisopropylamine (0.3 ml, 2.18 mmol) in THF (5 ml) at -78°C under nitrogen and the 
solution was stirred for 1 h. 3-Methyl-5H-isoxazolo[ 4,3-c ]pyridin-4-one 73 (100 mg, 0.66 
mmol) in THF (20 ml) was then added dropwise and the mixture stirred for 1 h. 
Benzaldehyde (l ml, 9.93 mmol) was then added and the reaction mixture stirred for 5 min at 
-78°C. The reaction was quenched with water (20 ml) and acidified with 2M hydrochloric 
acid (20 ml). The product was extracted from the aqueous solution with ethyl acetate (2 x 30 
ml) and the organic fractions were combined, washed with brine (30 ml), dried and 
evaporated under reduced pressure to a yellow oil, which was purified by column 
chromatography on silica using light petroleum / ethyl actetate (1: I, v/v) as eluent to leave 
the title compound 104 (30 mg, 17%) as a pale yellow solid; mp 180-182 °C (from ethyl 
acetate /light petroleum [1:1]); vrnax(l(Br)/cm·1 3360, 3193, 3075, 1666, 1646, 1579, 1457, 
1373, 1217, 1045 & 791; IiH(250 MHz; [CD3hSO) 3.50 (2 H, d, J 8.0, CHCH2), 5.15 (I H, 
m, CH2CH), 5.70 (I H, d, J5.0, CHOH), 6.35 (1 H, d, J8.0, NHCHCH), 7.13 (I H, dd, J8.0 
& 6.0, NHCH), 7.32-7.36 (5 H, m, Ar-CH) & 10.81 (l H, d, J 6.0, NH); Iic(lOO MHz; 
[CD3hSO) 37.0 (CH2), 70.4 (CH), 92.5 (CH), 125.6 (CH), 127.2 (CH), 128.1 (CH), 135.0 
(CH), 144.3 (C), 158.1 (C), 159.5 (C) & 174.3 (C); mlz (El) 257.0924 ([M+W], CI4H13N203 
requires 257.0921), 150 (100%), 137 (43), 105 (67), 77 (94), 51 (70) & 43 (62). 
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MethodB 
3-Methyl-5H-isoxazolo[4,3-cJpyridin-4-one 73 (100 mg, 0.66 mmol) was added to a solution 
of n-butyllithium (0.6 ml of 2.5M solution in hexanes, 1.45 mmol) in THF (20 ml) at -78°C 
under nitrogen and the solution was stirred for I h. Benzaldehyde (I m~ 0.993 mmol) was 
then added and the reaction mixture stirred for 5 min at _78°C and the same work up as for 
method A was utilized to give the title compound 104 (I 06 mg, 63%) as a pale yellow solid, 
data in agreement with a sample prepared by method A. 
3-Ethyl-5H-isoxazolo[4,3-c]pyridin-4-one 103 
N 
H 
o 
.. 
The same procedure (method A) was used as for the formation of 3-(2-hydroxy-2-
phenylethyl)-5H-isoxazolo[4,3-cJpyridin-4-one 104 incorporating the following quantities: 3-
methyl-5H-isoxazolo[ 4,3-c Jpyridin-4-one 73 (IOO mg, 0.66 mmol), diisopropylamine (0.2 ml, 
1.47 mmol), n-butyllithium (0.6 ml of 2.5M solution in hexanes, 1.47 mmol) and methyl 
iodide (I ml) to give the title compound 103 as a yellow solid that was not completely 
characterised; oH(250 MHz; [CD3hSO) 1.30 (3 H, t, J 8.0, CH2CH3), 3.1 8 (2 H, q, J 8.0, 
CH3CH2), 6.32 (I H, d, J 8.0, NHCHCH), 7.12 (1 H, dd,.J 8.0 & 6.0, NHCH) & 10.56 (I H, 
br s, NH); oc(100 MHz; [CD3hSO) 11.3 (CH3), 20.2 (CH2), 92.5 (CH), 107.4 (C), 135.1 
(CH), 158.3 (C), 159.5 (C) & 177.5 (C). 
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5-terl-Butyloxycarbonyl-3-methyl-4H-isoxazolo[4,3-c]pyridine-4-one 106 
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The same procedure (method A) was used as for the formation of 3-(2-hydroxy-2-
phenylethyl)-5H-isoxazolo[4,3-c]pyridin-4-one 104 incorporating the following quantities: 3-
methyl-5H-isoxazolo[4,3-c]pyridin-4-one 73 (200 mg, 1.33 mmol), diisopropylamine (0.19 
ml, 1.33 mmol), n-butyllithium (0.52 ml of 2.5M solution in hexanes, 1.33 mmol) and tert-
butyl dicarbonate (292 mg, 1.33 mmol) to give the title compound 106 (287 mg, 86%) as a 
yellow solid; mp 73-76 °C (from DCM); vmax(DCM)/cm·1 3100, 2983, 1748, 1711, 1644, 
1586, 1459, 1369, 1278, 1153,& 1087; ~H(250 MHz; CDCh) 1.63 (9 H, s, QCH3h), 2.85 (3 
H, s, 5-CHJ) 6.37 (l H, d, J 8.0, NHCHCH) & 7.57 (l H, d, J 8.0, NHCH); ~c(100 MHz; 
CDCh) 13.1 (CH3), 27.7 (CH3), 86.0 (CH3), 96.2 (CH), 108.9 (C), 134.1 (CH), 157.7 (C), 
160.8 (C), 174.1 (C) & 175.8 (C); mlz (El) 250.0954 (M+, C12HI4N204 requires 250.0954), 
177 (7),150 (100%), I37 (6),108 (8), 95 (7),80 (8),57 (86) & 43 (25). 
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3-[2-Hydroxy-2-(4-nitrophenyl)ethyl]-5H-isoxazolo[4,3-c]pyridin-4-one 
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The same procedure (method B) was used as for the formation of 3-(2-hydroxy-2-phenyl-
ethyl)-5H-isoxazolo[4,3-c]pyridine-4-one 104 incorporating the following quantities: 3-
methyl-5H-isoxazolo[4,3-c]pyridin-4-one 73 (lOO mg, 0.66 mmol), n-butyllithium (0.6 ml of 
2.5M solution in hexanes, 1.45 mmol) and 4-nitrobenzaldehyde (2 g, 13.24 mmol) to give the 
title compound 107 (177 mg, 89%) as a yellow solid; decomposes 200-220 °C; vmax(KBr)/cm· 
13420,2909,2365, 1670, 1641, 1511, 1351, 1226 & 1058; 8H(250 MHz; [CD3hSO) 3.52 (2 
H, d, J7.0, CHCH2), 5.30 (1 H, m, CH2CH), 6.03 (I H, d, J 5.0, CHOH), 6.32 (I H, d, J7.5, 
NHCHCH), 7.10 (1 H, dd, J 6.0 & 7.5, NHCH), 7.63 (2 H, d, J 8.5, Ar-CH), 8.20 (2 H, d, J 
8.5, Ar-CH) & 10.83 (1 H, d, J 5.5, NH); 8c(100 MHz; [CD3hSO) 36.6 (CH2), 69.7 (CH), 
92.6 (CH), 108.8 (C), 123.4 (CH), 126.9 (CH), 135.1 (CH), 146.7 (C), 151.9 (C), 158.1 (C), 
159.5 (C) & 173.5 (C); mlz (ES) 302.0773 ([M+H]+' C14H12N30S requires 302.0771), 284 
(40),245 (8),163 (10), 119 (24),102 (47),86 (100%) & 58 (63). 
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The same procedure (method B) was used as for the formation of 3-(2-hydroxy-2-
phenylethyl)-5H-isoxazolo[4,3-cJpyridine-4-one 104 incorporating the following quantities: 
3-methyl-5H-isoxazolo[4,3-cJpyridin-4-one 73 (100 mg, 0.66 mmol), n-butyllithium (0.6 ml 
of 2.5M solution in hexanes, 1.45 mmol) and trans-cinnamaldehyde (2 ml, 15.88 mmol) to 
give the title compound 108 (157 mg, 84%) as a yellow solid; mp 160-162 °C (from ethyl 
acetate flight petroleum [1:1]); vmax(KBr)!cm·1 3420,2909,2365, 1684, 1646, 1589, 1448, 
1374, 1228 & 1063; BH(250 MHz; [CD3hSO) 3.40 (2 H, d, J 6.5, CHCH2), 4.72 (I H, m, 
CH2CH), 5.45 (I H, d, J 5.0, CHOH), 6.31-6.34 (I H, m, CH2CHCH), 6.38 (1 H, d, J 6.0, 
NHCHCH), 6.50 (I H, d, J 16.0, CHCH=CH), 7.09 (I H, dd, J6.0 & 7.5, NHCH) 7.18-7.41 
(5 H, m, Ar-CH) & 10.82 (1 H, d, J 6.0, NH); Bc(100 MHz; [CD3hSO) 35.2 (CH2), 69.2 
(CH), 92.6 (CH), 108.7 (C), 126.3 (CH), 128.3 (CH), 128.6 (CH), 129.1 (CH), 132.3 (CH), 
135.0 (C), 136.4 (CH), 158.1 (C), 159.6 (C) & 174.00 (C); mlz (El) 282.1007 (M', 
CI6HI4N203 requires 282.1004),264 (10),150 (100%),133 (27),115 (IS), 105 (32), 91 (17), 
77 (25), 69 (7), 55 (I 0) & 43 (11). 
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3-[2-Hydroxy-2-(4-methoxyphenyl)ethyl]-5H-isoxazolo[4,3-c]pyridin-4-one 
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The same procedure (method B) was used as for the formation of 3-(2-hydroxy-2-
phenylethyl)-5H-isoxazolo[4,3-c]pyridin-4-one 104 incorporating the following quantities: 3-
methyl-5H-isoxazolo[4,3-c]pyridin-4-one 73 (lOO mg, 0.66 mmol), n-butyllithium (0.6 ml of 
2.5M solution in hexanes, 1.45 mmol) and 4-methoxybenzaldehyde (2 ml, 16.44 mmol) to 
give the title compound 109 (115 mg, 61%) as a pale yellow solid; mp 192-194 °C (from 
ethyl acetate / light petroleum [1:1]); (Found: C, 62.6; H, 4.7; N, 9.7. ClsHl4N402 requires C, 
63.0; H, 4.9; N, 9.8 %); vmax(KBr)/cm-1 3409, 3195, 3077, 2357, 2339, 1667, 1644, 1615, 
1585, 1513, 1373, 1339, 1279, 1247, 1036 & 800; 15Frt:250 MHz; [CD3]2S0) 3.44 (2 H, m, 
CHCH2), 3.72 (3 H, s, OCH3), 5.06 (1 H, m, CH2CH), 5.57 (I H, d, J5.0, CHOH), 6.31 (1 H, 
d, J 8.5, NHCHCH), 6.86 (2 H, d, J 8.5, Ar-CH), 7.09 (I H, dd, J 7.5 & 5.5, NHCH), 7.26 (2 
H, d, J 8.5, Ar-CH) & 10.80 (I H, d, J 5.5, NH); I5c(lOO MHz; [CD3]2S0) 37.0 (CH2), 55.0 
(CH3), 70.0 (CH), 92.5 (CH), 108.6 (C), 113.5 (CH), 126.8 (CH), 135.0 (C), 136.3 (CH), 
158.1 (C), 158.4 (c), 159.5 (C) & 174.3 (C); m/z (El) 286.0949 (W, Cl5Hl4N204 requires 
286.0954),268 (3), 256 (10), 213 (2), 185 (2), 150 (93), 137 (100%), 115 (4), 109 (15), 94 
(11),77 (24), 69 (7), 55 (8) & 44 (12). 
118 
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The same procedure (method B) was used as for the formation of 3-(2-hydroxy-2-
phenylethyl)-5H-isoxazolo[4,3-cJpyridin-4-one 104 incorporating the following quantities: 3-
methyl-5H-isoxazolo[4,3-cJpyridin-4-one 73 (100 mg, 0.66 mmol), n-butyIIithium (0.6 ml of 
2.5M solution in hexanes, 1.45 mmol) and tiglic aldehyde (2 ml, 20.74 mmol) to give the title 
compound 111 (109 mg, 70%) as a pale yellow solid; mp 140°C (from DCM); (Found: C, 
61.0; H, 5.7; N, 11.7. CI2HI4N203 requires C, 61.5; H, 6.0; N, 12.0%); vmax(CDCh)/cm·1 
3274,2920,2362, 1683, 1652, 1645, 1558, 1506, 1326, 1218 & 1058; /)H(250 MHz, CDCh) 
1.58 (3 H, d, J 7.0, CHCH;), 1.71 (3 H, s, CH;), 3.35-3.58 (2 H, rn, CHCH2), 4.55 (I H, m, 
CH2CH), 5.52 (I H, q, J 7.0, CH3CH), 6.46 (I H, d, J 7.5, NHCHCH), 6.97 (1 H, dd, J 5.0 & 
7.5, NHCH) & 9.62 (I H, br, NH); /)c(IOO MHz, CDCh) 11.5 (CH3), 12.8 (CH3), 34.3 (CH2), 
75.4 (CH), 96.6 (CH), 109.3 (C), 121.4 (CH), 133.0 (CH), 136.3 (C), 158.2 (C), 161.8 (C) & 
175.1 (C); mlz (El) 234.1005 (M', CI2H14N203 requires 234.1004), 216 (3), 177 (4), 150 
(100%), 137 (14), 121 (3), 108 (6), 95 (7), 85 (13), 80 (7), 67 (4),55 (6) & 43 (9). 
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The same procedure (method B) was used as for the formation of 3-(2-hydroxy-2-
phenylethyl)-5H-isoxazolo[4,3-c]pyridin-4-one 104 incorporating the following quantities: 3-
methyl-5H-isoxazolo[4,3-c]pyridin-4-one 73 (lOO mg, 0.66 mmol), n-butyllithium (0.6 ml of 
2.5M solution in hexanes, 1.45 mmol) and crotonaldehyde (2 ml, 22.23 mmol) to give the 
title compound 110 (142 mg, 97 %) as a pale yellow solid; mp 157-160 °C (from DCM); 
(Found: C, 59.3; H, 5.2; N, 12.5. CIIH12N203 requires C, 60.0; H, 5.5; N, 12.7%); 
vmax(DCM)/cm-1 3425, 2924, 2360, 1668, 1645, 1505, 1541 & 1377; IiH(250 MHz, CDCh) 
1.68 (3 H, d, J 6.0, CH3), 3.47 (2 H, d, J 6.0, CHCH2), 4.62 (I H, m, CH2CH), 5.56 (1 H, dd, 
J 6.5 & 15.5, CH3CH), 5.76 (I H, dd, J6.5 & 15.0, CHCH) 6.44 (1 H, d, J7.5, NHCHCH), 
7.00 (1 H, dd, J7.5 & 5.5, NHCH) & 9.72 (1 H, br, NH); 1ic(100 MHz; CDCh) 17.7 (CH3), 
35.9 (CH2), 70.8 (CH), 95.5 (CH), 109.5 (C), 128.0 (CH), 132.1 (CH), 132.9 (CH), 158.2 (C), 
161.8 (C) & 174.6 (C); m/z (El) 220.0847 (W, CIIH12N203 requires 220.0848), 150 (100%), 
137 (9),121 (3), 108 (6), 95 (7), 80 (4),71 (13), 53 (4) & 41 (7). 
120 
3-(2-Hydroxy-3,5-dimethylhept-3-enYI)-5H-isoxazolo[4,3-c]pyridin-4-one 
114 
N-O N-O OH 
~ ~ ~ 
.. 
N H 
The same procedure (method B) was used as for the formation of 3-(2-hydroxy-2-
phenylethyl)-5H-isoxazolo[4,3-c]pyridin-4-one 104 incorporating the following quantities: 3-
methyl-5H-isoxazolo[4,3-cJpyridin-4-one 73 (134 mg, 0.89 mmol), n-butyllithium (0.81 ml 
of 2.5M solution in hexanes, 1.97 mmol) and E-2,4-dimethylhex-2-enal 30 (2.24 g, 17.75 
mmol) to give the title compound 114 (148 mg, 60%) as a pale yellow solid; mp I 10-II5 °C 
(from DCM); (Found: C, 65.0; H, 7.3; N, 10.1. ClsH2oN2<1 requires C, 65.2; H, 7.3; N, 
10.1%); vmax(DCM)!cm·1 3226,3093,2958,2925,2871,1684,1676,1653,1647,1585, 1507, 
1457, 1370, 1218 & 1059; ~250 MHz; CDCb) 0.65-0.74 (3 H, m, CH2CHJ), 0.77-0.83 (3 
H, m, CHCHJ), 1.02-1.21 (2 H, m, CH3CH2), 1.68 (3 H, s, CHJ), 2.13-2.28 (I H, hep, 
CH3CH), 3.43-3.59 (2 H, m, CHCH1), 3.94 (I H, br, OH), 4.56 (I H, dd, J 5.5 & 12.0, 
CH2CH), 5.14 (I H, d, J9.5, C=CH), 6.39 (I H, d, J7.5, NHCHCH), 6.98 (I H, d, J 5.5 & 
7.5, NHCH) & 10.20 (I H, br, NH); Iic(75 MHz; CDCb) 11.8 (CH3), 12.0 (CH3), 20.4 (CH3), 
30.0 (CH2)' 33.6 (CH), 34.3 (CH2), 75.4 (CH), 95.4 (CH), 109.3 (C), 133.0 (CH), 133.2 
(CH), 134.0 (C), 158.4 (C), 161.9 (C) & 174.9 (c); (ES) 294.1815 ([M+NH/] C1sH24N303 
requires 294.1 8 12)(EI) 150 (15),137 (8), III (4),97 (18),69 (22),55 (37) & 43 (100%). 
121 
7-(4-Benzyloxyphenyl)-3-(2-Hydroxypent-3-enyl)-5H-isoxazo10[4,3-
c]pyridin-4-one 141 
BnO BnO OH 
The same procedure (method B) was used as for the formation of 3-(2-hydroxy-2-
phenylethyl)-5H-isoxazolo[4,3-c]pyridin-4-one 104 incorporating the following quantities: 7-
(4-benzyloxyphenyl)-3-methyl-5H-isoxazolo[4,3-c]pyridin-4-one 133 (16 mg, 0.048 mmol), 
n-butyllithium (0.05 ml of 2.5M solution in hexanes, 0.13 mmol) and crotonaldehyde (I ml, 
I I. 13 mmol) to give the title compound 141 (8 mg, 37%) as a white solid; mp 165°C (from 
DCM); IlH( 400 MHz, CDCh) 1.70 (3 H, d, J 6.5, CH;), 3.54 (2 H, m, CHCH2), 4.65 (I H, m, 
J 7.0, CH2CH), 5.1 I (2 H, s, CH2), 5.58 (1 H. dd, J 6.5 & 15.0, CH3CH), 5.79 (1 H, dd, J 
15.0 & 6.5, CH2CHCH), 7.05 (2 H, d, J9.0, Ar-CH), 7.32-7.48 (5 H, m, Ar-CH), 7.67 (2 H, 
d, J9.0, Ar-CH) & 8.81 (1 H, br, NH); 1lc(100 MHz) 17.7 (CH3), 36.0 (CH2), 70.1 (CH2), 
71.3 (CH), 115.2 (CH), 127.5 (CH), 128.1 (CH), 128.3 (CH), 128.6 (CH), 128.6 (CH) & 
132.1 (CH); m/z (El) 403.1651 ([M+lt], C24H22N204 requires 403.1652),332 (14), 241 (20), 
91 (100%),84 (20), 70 (26), 49 (35) & 41 (52). 
122 
7-(4-Benzyloxy-phenyl)-3-(2-hydroxy-3,5-dimethyl-hept-3-enyl)-5H-
isoxazolo[4,3-c]pyridin-4-one 138 
BnO 
N 0 
H 
BnO ! 
N 0 
H 
The same procedure (method B) was used as for the formation of 3-(2-hydroxy-2-
phenylethyl)-5H-isoxazolo[4,3-cJpyridin-4-one 104 incorporating the following quantities: 7-
(4-benzyloxyphenyl)-3~methyl-5H-isoxazolo[ 4,3-c Jpyridin-4-one 133 (36 mg, 0.11 mmol), n-
butyllithium (0.1 ml of 2.5M solution in hexanes, 0.24 mmol) and E-2,4-dimethylhex-2-enal 
(0.27 g, 4.8 mmol) to give the title compound 138 as a white solid which was not completely 
characterised; mp 178°C (from DCM); oH(400 MHz, CDCh) 0.71-0.76 (3 H, m, CH2CHJ), 
0.83-0.86 (3 H, m, CHCHJ), 1.08-1.30 (2 H, m, CH3CH2), 1.72 (3 H, s, CHJ), 2.18-2.27 (l H, 
m, CH3CH) 3.54-3.62 (2 H, m, CHCH2) 4.58 (1 H, m, CH2CH), 4.90 (l H, br, OH), 5.14 (2 
H, s, CH2), 5.26 (l H, cl, J 6.5, C=CH), 7.04 (2 H, d, J 9.0, Ar-CH), 7.08 (1 H, cl, J 5.5, 
NHCH), 7.27-7.49 (5 H, m, Ar-CH), 7.65 (2 H, d, J9.0, Ar-CH & 9.71 (l H, br, NH). 
123 
3-(2-Phenylethenyl)-5H-isoxazolo[4,3-c]pyridin-4-one 115 
N-O OH 
~f? Ph Ph 
• 
° 
p-Toluenesulfonic acid (96 mg, 0.51 mmol) was added to a solution of 3-(2-hydroxy-2-
phenylethyl)-5H-isoxazolo[4,3-c]pyridin-4-one 104 (130 mg, 0.51 mmol) in toluene (30 ml) 
and the mixture was heated overnight under Dean/Stark conditions. This was then repeated 
until the reaction had gone to completion by TLC to give the title compound 115 (86 mg, 
7\%) as a yellow solid; mp 215°C (from ethyl acetate); vmax(CHCh)!cm·1 3191,2923,2334, 
1674, 1643, 1579, 1454, 1371 & 1257; IlH(250 MHz; [CD3hSO) 6.39 (1 H, d, J 7.5, 
NHCHCH), 7.18 (I H, d, J7.5, NHCH), 7.41-7.52 (3 H, m, Ar-CH), 7.58 (I H, d, J 16.5, Ph-
CH), 7.75 (2 H, m, Ar-CH), 8.13 (1 H, d, J 16.5, Ph-CH=CH) & 10.96 (I H, br, NH); 1lc(100 
MHz; [CD3hSO) 92.5 (CH), 107.4 (C), 111.9 (CH), 127.8 (CH), 129.0 (CH), 130.2 (CH), 
134.7 (C), 135.2 (CH), 139.6 (CH), 158.8 (C), 159.3 (C) & 169.1 (C); mlz (El) 238.0741 (M+, 
CI4HION202 requires 238.0741), 238 (100%),209 (12), 181 (8), 136 (11), 103 (27), 97 (22), 
83 (21), 77 (26),57 (34) & 43 (19). 
124 
3-[2-(4-Methoxyphenyl)ethenyl]-5H-isoxazolo[4,3-c]pyridin4-one 117 
OH N-O 
~ ~ ~ ~ 
-
0 OMe N 
~ 
0 OMe 
H 
p-Toluenesulfonic acid (44 mg, 0.14 mmol) was added to a solution of 3-[2-hydroxy-2-(4-
methoxyphenyl)ethyl]-5H-isoxazolo[4,3-c]pyridin-4-one 109 (40 mg, 0.14 mmol) in toluene 
(30 ml) and the mixture was heated under overnight Dean/Stark conditions. This was then 
repeated until the reaction had gone to completion by TLC to give the title compound 117 (37 
mg, 100%) as a yellow solid; mp 220°C (from ethyl acetate); (Found: C, 66.5; H, 4.55; N, 
10.2. C,sH'2N203 requires C, 67.2; H, 4.5; N, 10.4%); vrnax(CHCh)!cm" 2931, 2898, 2353, 
2338,1666,1643,1514,1380,1255,1177 & 1031; oH(250 MHz; [CD3hSO) 3.82 (3 H, s, 
OCHJ), 6.35 (I H, d, J 7.5, NHCHCH), 7.02 (2 H, d, J 9.0, Ar-CH), 7.15 (I H, dd, J 5.5 & 
7.5, NHCH), 7.38 (I H, d, J 16.5, Ph-CH), 7.69 (2 H, d, J 8.5, Ar-CH), 8.04 (l H, d, J 17.0, 
Ph-CH=CH) & 10.90 (I H, d, J 6.0, NH); oc(IOO MHz; [CD3hSO; Me4Si) 54.9, 92.4, 108.0, 
113.6, 113.8, 114.1, 128.3, 129.7, 131.1, 135.1,158.1, 159.3 & 173.8; m/z (El) 268.0849 
(M+, C,sH'2N203 requires 268.0848), 268 (100%), 225 (14), 185 (33), 167 (16), 149 (42), 
135 (27),97 (33), 83 (36), 69 (48), 57 (60) & 43 (56). 
125 
3-(4-Phenylbuta-1 ,3-dienyl)-5H-isoxazolo[4,3-c]pyridin-4-one 116 
N 
H 
o 
OH 
Ph 
• 
Ph 
p-Toluenesulfonic acid (93 mg, 0.44 mmol) was added to a solution of 3-(2-Hydroxy-4-
phenylbut-3-enyl)-5H-isoxazolo[4,3-c]pyridin-4-one 108 (125 mg, 0.44 mmol) in toluene 
(100 ml) and the mixture was heated under overnight Dean/Stark conditions. This was then 
repeated until the reaction had gone to completion by TLC to give the title compound 116 
(116 mg, 99%) as a yellow solid; decomposes >200 QC; vmax(KBr)/cm-1 3173, 3024, 2902, 
2364, 1694, 1636, 1609, 1371, 1274, 1055 & 984; IiH(250 MHz; [CD3hSO) 6.36 (I H, d, J 
7.5, NHCHCH), 7.09-7.44 (7 H, m), 7.61 (2 H, d, J 7.5, Ar-CH), 7.83 (1 H, dd, J 15.5 & 
16.0, Ph-CH=CH-CH) & 10.91 (1 H, d, J 5.5, NH); Iic(100 MHz; [CD3hSO) 92.5 (CH), 
107.2 (C), 115.1 (CH), 127.3 (CH), 128.0 (CH), 128.9 (CH), 129.0 (CH), 135.3 (CH), 136.1 
(CH), 139.8 (CH), 140.4 (CH), 158.8 (C), 159.4 (C) & 169.0 (C); mlz (El) 264.0902 (M', 
C1Jil2N202 requires 264.0900), 264 (100%), 256 (14), 235 (18), 217 (8), 150 (57), 136 (28), 
115 (20), 105 (30), 91 (38),77 (47),69 (12),51 (18) & 43 (21). 
126 
3-[2-(4-Nitrophenyl)-vinyl]-5H-isoxazolo[ 4,3-c]pyridin-4-one 118 
N-O OH N-O 
~ r ~ ~ 
-7'<: ~ 
N 0 NO, N 0 NO, H H 
Method A 
p-Toluenesulfonic acid (26 mg, 0.12 mmol) was added to a solution of 3-[2-hydroxy-2-(4-
nitrophenyl)-ethyl]-5H-isoxazolo[4,3-c]pyridin-4-one 107 (37 mg, 0.12 mmol) in toluene (30 
ml) and the mixture was heated overnight under Dean/Stark conditions, this was then 
repeated. 
MethodB 
Acetyl chloride (l0 ml) was added to solution of 3-[2-hydroxy-2-( 4-nitrophenyl)-ethyl]-5H-
isoxazolo[4,3-c]pyridin-4-one 107 (50 mg, 0.17 mmol) in methanol (30 ml) and the mixture 
was heated under reflux overnight. 
In both cases the elimination product 188 was not observed. 
127 
3-(3-Methylpenta-1 ,3-dienyl)-5H-isoxazolo[4,3-c]pyridin-4-one 120 
OH N-O 
I ~ # 
• 
N 0 N 0 H H 
p-Toluenesulfonic acid (86 mg, 0.45 mmol) was added to a solution of 3-(2-hydroxy-3-
methylpent-3-enyl)-5H-isoxazolo[4,3-cJpyridin-4-one 111 (96 mg, 0.45 mmol) in toluene (20 
ml) and the mixture was heated overnight under Dean/Stark conditions overnight to give the 
title compound 120 (80 mg, 90%) as a yellow solid; 15H(250 MHz; CDCb; Me4Si) 1.88 (3 H, 
d, J 7.0, CHCHJ), 1.92 (3 H, s, CH3), 6.10 (I H, q, J 7.0, CH3CH), 6.38 (I H, d, J 6.5, 
NHCHCH), 6.91 (I H, d, J 16.0, CH3C-CH), 6.99 (I H, dd, J 7.5 & 5.5, NHCH), 7.63 (I H, 
d, J 16.0, CH3CCH=CH) & 9.57 (I H, br, NH). 
128 
3-(Penta-1,3-dienyl)-5H-isoxazolo[4,3-c]pyridin-4-one 119 
OH 
N 0 
H 
p-Toluenesulfonic acid (1\9 mg, 0.57 mmol) was added to a solution of3-(2-hydroxypent-3-
enyl)-5H-isoxazolo[4,3-c]pyridin-4-one 110 (125 mg, 0.57 mmol) in toluene (50 ml) and the 
mixture was heated under overnight Dean/Stark conditions to give the title compound 119 
(38 mg, 33%) as a yellow solid; mp 115-120 °C (from ethyl acetate); Vrna.(CDCh)/cm·1 3067, 
2924,2359,1682,1644,1657,1504,1455 & 1376; 15H(250 MHz; CDCh) 1.89 (3 H, d,J6.0, 
CHJ), 6.15-6.43 (3 H, m), 6.90 (I H, d, J 16.0, CH3CH), 6.99 (I H, dd, J 5.5 & 7.5, NHCIl), 
7.52 (I H, dd, J 15.5, CH3CH~HCH) & 10.10 (1 H, br d, J5.0, Nil); 15c(lOO MHz; CDCh) 
18.6 (CH3), 93.8 (CH), 106.0 (C), 112.2 (CH), 130.1 (CH), 132.1 (CH), 138.4 (CH), 140.1 
(CH), 157.7 (C), 160.4 (C) & 169.7 (C); mlz (El) 202.0743 ~, Cl1HION20 2 requires 
202.0742),202 (100%), 182 (57),167 (66), 136 (29),115 (14), 107 (24), 91 (56), 77 (32),65 
(21),57 (13), 51 (16) & 41 (24). 
129 
3-(3,5-Dimethylhepta-1 ,3-dienyl)-5H-isoxazolo[4,3-cJpyridin-4-one 114 
p-Toluenesulfonic acid (85 mg, 0.45 mmol) was added to a solution of 3-(2-hydroxy-3,5-
dimethylhept-3-enyl)-5H-isoxazolo[4,3-cJpyridin-4-one 114 (Il2 mg, 0.41 mmol) in toluene 
(50 ml) and the mixture was heated at 70°C overnight to give the title compound 121 (34 
mg, 32%) as a yellow solid; vrnax(CDCh)/cm-1 3217,2959,2924, 1675, 1641, 1559, 1507, 
1457, 1368, 1340 & 1055; IiH(400 MHz; CDCh) 0.87 (3 H, t, J7.5, CH2CH3), 1.02 (3 H, t, J 
6.5, CHCH3), 1.24-1.47 (2 H, rn, CH3CH2), 1.93 (3 H, s, CH3), 2.45-2.58 (l H, sep, CH2CH), 
5.80 (l H, d, J 9.5, CH3CHCH), 6.41 (1 H, d, J 7.5, NHCHCH), 6.93 (l H, d, J 16.5, 
CH3CCH), 7.02 (l H, dd, J5.5 & 7.5, NHCH), 7.64 (1 H, d, J 16.5, CH3CCH;{;H) & 10.03 
(1 H, br, NH); Iic(100 MHz; CDCh) 11.9 (CH3), 12.3 (CH3), 21.0 (CH3), 30.0 (CH2), 35.2 
(CH), 95.1 (CH), 109.8 (CH), 131.5 (C), 132.6 (CH), 132.9 (C), 146.3 (CH), 149.2 (CH), 
158.7 (C), 161.4 (C) & 171.3 (C). 
130 
4-Amino-3-(4,6-dimethylocta-2,4-dienoyl)-1 H-pyridin-2-one 123 
NH2 
___ a I 
Molybdenum hexacarbonyl (37 mg, 0.14 mmol) was added to solution of 3-(3,5-
dimethylhepta-I,3-dienyl)-5H-isoxazolo[4,3-c]pyridin-4-one 121 (36 mg, 0.14 mmol) in 
acetonitrile (20 ml) and the solution heated to reflux for 3 h. The solution was filtered 
through celite, washing with ethyl acetate, and evaporated to give a crude yellow solid, which 
was purified by column chromatography on alumina using dichloromethane / methanol (95:5, 
v/v) as eluent to leave the title compound 123 (35 mg , 96%) as a clear yellow solid; 
decomposes 150 °C; vmax(KBr)/cm-1 3446,2959,2363,2344, 1653, 1647, 1635, 1623, 1616, 
1554, 1457, 1212, 1093,984 & 810; /)H(400 MHz; [CD3]2S0) 0.81 (3 H, t, J 7.0, CH2CH3), 
0.96 (3 H, d, J7.0, CHCH3), 1.23-1.43 (2 H, m, CH3CH2), 1.76 (3 H, s, CH3), 2.45 (1 H, sep, 
CH2CH), 5.67 (1 H, d, J 10.0, CH3CHCH), 5.76 (1 H, d, J 7.0, NHCHCH), 7.09 (I H, d, J 
15.0, CH3CCH), 7.16 (I H, t, J7.0, NHCH), 7.68 (1 H, d, J 15.5, CH3CCH=CH), 7.75 (I H, 
br, NHH), 9.64 (I H, br, NHH) & 10.52 (1 H, d, J 6.5, CH-NH); /)c(100 MHz; [CD3hSO) 
11.9 (CH3), 12.7 (CH3), 20.2 (CH3), 29.5 (CH2), 34.2 (CH), 98.4 (CH), 102.9 (CH), 126.9 
(C), 132.4 (CH), 137.6 (C), 143.7 (CH), 145.8 (CH), 161.7 (C), 163.3 (C) & 190.7 (C); mlz 
(ES) 261.1598 ([M+H]+' C1sH21N202 requires 261.1598), 169 (70), 137 (40), 111 (14), 102 
(100%),72 (95) & 58 (98). 
131 
4-Amino-3-(5-phenYlpenta-2,4-dienoyl)-1 H-pyridin-2-one 122 
Ph Ph 
• 
Molybdenum hexacarbonyl (55 mg, 0.21 mmol) was added to solution of 3-(4-phenylbuta-
1,3-dienyl)-5H-isoxazolo[4,3-cJpyridin-4-one 116 (55 mg, 0.21 mmol) in acetonitrile (20 ml) 
and the solution heated to reflux for 4 h. The solution was filtered through celite, washing 
with ethyl acetate and evaporated to give a crude yellow solid, which was purified by column 
chromatography on silica using dichloromethane / methanol (95:5, v/v) as eluent to leave the 
title compound 122 (8 mg, 32%) as a clear yellow solid; decomposes 200°C; vmax(KBr)/cm·1 
3414, 2924, 2360, 1653, 1647, 1635, 1617, 1576, 1559, 1517, 1457, 1448 & 1229; oH(250 
MHz; [CD3hSO) 5.78 (1 H, d, J 7.5, NHCHCH), 6.96-7.60 (9 H. m). 7.85 (1 H. d, J 14.5, 
PhCH=CHCH=CH), 9.66 (I H, br, NHH). 10.53 (I H, br, NHH) & 10.63 (I H, br d, J 5.0, 
NIl); oc(lOO MHz; [CD3hSO) 98.4 (C). 102.9 (CH). 127.0 (CH), 128.2 (CH), 128.5 (CH), 
129.2 (CH), 132.6 (CH), 136.4 (C), 137.7 (CH), 138.5 (CH). 139.0 (CH), 161.8 (c), 163.3 
(C) & 190.2 (C); mlz (ES) 267.1130 ([M+Ht Cl6HlSN202 requires 267.1128),267 (100%), 
157 (69),139 (30),135 (100),130 (24),102 (32). 72 (25) & 55 (8). 
132 
3-Acetyl-4-amino-1 H-pyridin-2-one 10255 
o 
.. 
N 0 
H 
Molybdenum hexacarbonyl (87 mg, 0.33 mmol) was added to solution of methyl-5H-
isoxazolo[4,3-c]pyridin-4-one 73 (50 mg, 0.33 mmol) in acetonitrile (30 ml) and the solution 
heated to reflux for 4 h. The solution was filtered through celite, washing with ethyl acetate 
and evaporated to give a crude yellow solid, which was purified by column chromatography 
on silica gel using dichloromethane / methanol (95:5, v/v) as eluent to leave the title 
compound 101 (13 mg , 26%) as a clear yellow solid; decomposes 215-219 °C (from 
dichloromethane:methanol [90:10, v/vI]) (lit.mp.,58 245-246 0C); 011(250 MHz; [CD3hSO) 
2.48 (3 H, s, CH3), 5.73 (I H, d, J 7.0, NHCHCB), 7.15 (I H, t, NHCH), 7.74 (1 H, br, 
NHH), 9.56 (1 H, br, NHH) & 10.52 (I H, br, NB); oc(100 MHz; [CD3hSO) 32.8 (CH3), 
98.1 (CH), 102.5 (C), 137.7 (CH), 161.3 (C), 163.4 (C) & 199.6 (C). 
133 
3-Acetyl-4-amino-5-(4-benzyloxyphenyl)-1 H-pyridin-2-one 134 
BnO ~ BnO ~ N-O NH2 0 
~ I ~ ~ ~ 
• 
N 0 
H 
Molybdenum hexacarbonyl (40 mg, 0.15 mmol) was added to a solution which contained 7-
(4-benzyloxyphenyl)-3-methyl-5H-isoxazolo[ 4,3-c ]pyridin-4-one 133 and 7 -Iodo-3-methyl-
5H-isoxazolo[4,3-c]pyridin-4-one 127 (50 mg) in acetonitrile (20 ml) and the solution heated 
to reflux for 4 hrs. The solution was filtered through celite, washing with methanol and 
evaporated to give a crude yellow solid, which was purified by column chromatography on 
silica using dichloromethane / methanol (98:2, v/v) as eluent to leave the title compound 134 
(21 mg) as a clear yellow solid; decomposes >250 DC; oH(400 MHz; CDCh) 2.52 (3 H, s, 
CH3), 5.14 (2 H, s, Ph-CH2), 6.41 (I H, br, NHH), 7.08 (3 H, m), 7.10 (2 H, d, J8.5, Ar-CH), 
7.38-7.43 (5 H, m, Ar-Cll), 10.13 (1 H, br, NHH) & 10.79 (I H, br, Nll); oc(IOO MHz; 
CDCh) 33.0 (CH3), 69.2 (CH2), 99.9 (CH3), 102.1 (C), 108.1 (C), 110.4 (C), 115.3 (CH), 
125.8 (C), 127.7 (CH), 127.9 (CH), 128.5 (CH), 131.0 (CH), 137.0 (CH), 158.1 (C), 159.4 
(C) & 162.8 (C). 
134 
tert-Butylpropylideneamine 11222 
H~ 
Propionaldehyde (16 ml, 0.125 mol) was added dropwise over the course of 2 h to ter/-
butylamine (13.1 ml, 0.125 mol) stirred at 0 DC. When the addition was complete stirring 
was stopped and potassium hydroxide (5 g) added. The solution was left to separate at 0 DC 
overnight before the yellow upper layer was decanted. This was distilled over potassium 
hydroxide at atmospheric pressure and the title compound 112 (10.014 g, 65 %) collected as a 
clear colourless oil which was stored over molecular sieves at ODC; bp 103·105 DC (Iit.bp.,22 
105 DC); vrnax(DCM)!cm-] 3100,2983, 1748, 1711, 1644, 1586, 1459, 1369, 1278, 1153 & 
1087; oH(250 MHz; CDCb) 0.97 (3 H, t, J 7.5, CH2CHJ), 1.1 0 (9 H, s, qCHJh), 2.17 (2 H, 
qd, J 7.5 & 5.0, CH3CH2) & 7.52 (I H, t, J 5.0, N=CH); oc(100 MHz; CDCb) 11.2 (CH3), 
30.2 (CH3), 55.9 (CH2), 102.1 (C) & 160.6 (CH) which is in accordance with the data 
published in the Iiterature.22 
135 
E.2,4.Dimethylhex.2-enal 3022 
• 
H 
n-Butyllithium (23 ml of2.5M solution in hexanes, 0.58 mmol) was added dropwise over 10 
min to a solution of freshly distilled tert-butylpropylideneamine 112 (6.42 g, 0.052 mmol) in 
tetrahydrofuran (25 ml) at -78 °C under nitrogen and the solution stirred for 30 min. 2-
Methylbutyraldehyde (5.58 ml, 0.052 mmol) was added dropwise and the solution allowed to 
warm to 0 °C and stirred for 2 h at this temperature. Citric acid solution (2M, 100 m!) was 
added and the biphasic mixture vigorously stirred for 24 h at room temperature. The mixture 
was extracted with dichloromethane (2 x 100 ml). The combined extracts were dried and 
evaporated under reduced pressure to leave a clear oil which was purified by column 
chromatography on silica using dichloromethane as eluent to leave the title compound 30 
(2.485 g, 38%) as a clear oil; vmax(film)!cm-I 2961, 2928, 2874, 2815, 2706, 1691, 1640, 
1456, 1217, 1034 & 830; ()H(400 MHz; CDCh) 0.86 (3 H, t, J7.5, CH2CH3), 1.04 (3 H, d, J 
6.5, CHCH3), 1.30-1.47 (2 H, m, CH3CH2), 1.72 (3 H, s, CH3), 2.58-2.62 (1 H, m, CH2CH), 
6.28 (I H, d, J 10.0, CH3C=>CH) & 9.38 (I H, s, CHO); ()c(IOO MHz; CDCh) 11.3 (CH3), 
13.7 (CH3), 21.4 (CH2), 31.4 (CH3), 37.1 (CH), 140.1 (CH), 162.3 (C) & 197.5 (C) which is 
in accordance with data published in the literature.22 
136 
Hydrogen peroxide (30%, 50 ml) and molybdenum(VI) oxide (lOg, 34.74 mmol) were 
heated at 35°C for 4 h, the solution was cooled to room temperature and filtered through 
celite. The filtrate was cooled to 10°C and DMPU (8.9 g, 69.48 mmol) added dropwise over 
5 min, resulting in the formation of a yellow crystalline precipitate. The solution was stirred 
for a further 15 min and the precipitate filtered and recrystallised (methanol) to give the title 
compound 136 (2.83 g, 25%) as fine yellow needles; mp 100°C (from methanol with 
decompostion) (lit.mp.,53 76°C [with decomposition]); (Found: C, 22.6; H, 4.3; N, 8.6. 
C6H13N204Mo requires C, 22.4; H, 4.4; N, 8.7%); vrn.x(KBr)/cm-t 1614,966,861,749 & 580 
which is in accordance with data published in the literature. 
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Mo05.py.DMPU (MoOPD) 13752 
H H 
"'-0/ 
0"" I /0 
b/\\"b 
o 
"'-N)lN/ 
• 
U 
MoOs.DMPU.H20 136 (2.833 g, 8.79 nunol) was dried over phosphorus pentoxide under 
vacuum (0.5 mmlHg) for 24 h to give MoOs.DMPU (2.644 g, 8.69 mmol). MoOs.DMPU 
(2.644 g, 8.69 mmol) was then dissolved in tetrahydrofuran (20 ml) and filtered through 
celite. Dry pyridine (0.71 ml, 8.69 mmol) was added to the filtrate over 10 min to yield a fine 
yellow powder which was dried and washed with diethyl ether to give the title compound 137 
(0.677 g, %); mp 102°C (with decomposition) (1it.,S3 93.5-94.5 0C); vmax(KBr)!cm'l 2945, 
2873, 1592, 1484, 1443, 1323, 1245, 1072,957,865,749,710,624,580 & 538 which is in 
accordance with data published in the literature. 
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Crystal Structure Data 
Data were collected at 150(2) K on a Bruker SMART 1000 diffi'actometer. The structure was 
solved by direct methods and refined by full-matrix least-squares on p2 using the SHELXTL 
suite of programsl . All the non-hydrogen atoms were refined with anisotropic atomic 
displacement parameters, and the hydrogen atoms bonded to carbon were inserted at 
calculated positions using a riding model. The hydrogen atom bonded to nitrogen was located 
from difference maps and their coordinates refined; they were assigned a common, fixed 
displacement parameter. Details of the data collection and structure refinement are given in 
Table 1. 
1. Sheldrick a.M. (2001). SHELXTL version 6.12, Bruker AXS, Madison, Wisconsin, USA. 
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Table I. Crystal data and structure refinement for 73. 
Identification code 73 
Empirical fonnula 
Fonnula weight 
Temperature 
Wavelength 
Crystal system 
Space group 
Unit cell dimensions 
Volume 
Z 
Density (calculated) 
Absorption coefficient 
F(OOO) 
Crystal size 
Crystal description 
Theta range for data collection 
Index ranges 
Reflections collected 
Independent reflections 
Completeness to theta ~ 24.98° 
Absorption correction 
Max. and min. transmission 
Refinement method 
Data 1 restraints 1 parameters 
Goodness-of-fit on F2 
Final R indices [1>2sigma(I)) 
R indices (all data) 
Largest diff. peak and hole 
C7H6N202 
150.14 
150(2) K 
0.71073 A 
Orthorhombic 
Pbca 
a ~ 7.520(3) A 
b ~ 13.024(3) A 
c ~ 13.545(5) A 
1326.7(8) A' 
8 
1.503 Mglm' 
0.114 mm" 
624 
0.43 x 0.19 x 0.18 mm' 
colourless block 
3.01 to 24.98°. 
-8<~h<~8, -15<~k<~15, -15<~I<~15 
6334 
1150 [R(int) ~ 0.0231) 
99.5% 
Semi-empirical from equivalents 
1.00000 and 0.931666 
Full-matrix least-squares on F2 
1150/0/104 
1.060 
RI ~ 0.0362, wR2 ~ 0.0935 
RI ~ 0.0453, wR2 ~ 0.1013 
0.454 and -0.192 e.k' 
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Table 2. Atomic coordinates (x 10") and equivalent isotropic displacement parameters (A2x 10') 
for 73. V(eq) is defined as one third of the trace of the orthogonalized VU tensor. 
x y z U(eq) 
0(1) 1765(2) 11001(1) 1052(1) 29(1) 
N(I) 2496(2) 11881(1) 1545(1) 29(1) 
C(1) 2231(2) 11685(1) 2490(1) 25(1) 
C(2) 2718(2) 12306(1) 3327(1) 28(1) 
C(3) 2229(2) 11944(1) 4217(1) 29(1) 
N(2) 1342(2) 11017(1) 4352(1) 27(1) 
C(4) 854(2) 10361(1) 3609(1) 24(1) 
0(2) 58(2) 9545(1) 3770(1) 30(1) 
C(5) 1362(2) 10729(1) 2639(1) 23(1) 
C(6) 1113(2) 10336(1) 1717(1) 25(1) 
C(7) 329(3) 9367(1) 1350(1) 32(1) 
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Table 3. Bond lengths [A] and angles [0] for 73. 
0(1)-C(6) 1.342(2) 
O(I)-N(I) 1.4356(19) 
N(I)-C(I) 1.320(2) 
C(I)-C(5) 1.421(3) 
C(I)-C(2) 1.439(3) 
C(2)-C(3) 1.345(3) 
C(3)-N(2) 1.391(2) 
N(2)-C(4) 1.369(2) 
C(4)-O(2) 1.240(2) 
C(4)-C(5) 1.450(2) 
C(5)-C(6) 1.363(2) 
C(6)-C(7) 1.478(3) 
C(6)-0(1)-N(I) 110.05(13) 
C(I)-N(I)-O(I) 103.87(14) 
N(I)-C(I)-C(5) 112.03(15) 
N(I)-C(I)-C(2) 128.10(17) 
C(5)-C(I)-C(2) 119.86(15) 
C(3)-C(2)-C(I) 116.01(17) 
C(2)-C(3)-N(2) 123.61(17) 
C(4)-N(2)-C(3) 124.91(15) 
O(2)-C(4)-N(2) 122.32(16) 
O(2)-C(4)-C(5) 124.74(16) 
N(2)-C(4)-C(5) 112.93(15) 
C(6)-C(5)-C(I) 105.27(15) 
C( 6)-C( 5)-C( 4) 132.08(17) 
C(I )-C( 5)-C( 4) 122.60(15) 
O(I)-C(6)-C(5) 108.77(15) 
O( I )-C( 6)-C(7) 118.08(15) 
C(5)-C(6)-C(7) 133.15(16) 
Symmetry transformations used to generate equivalent atoms: 
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Table 4. Anisotropic displacement parameters (A'x 10') for 73. The anisotropic 
displacement factor exponent takes the fonn: _24'[ h' a"V" + ... + 2 h k a* b* V12 l 
V" U" V33 U'3 VI3 VI2 
0(1) 35(1) 31(1) 20(1) 2(1) 1(1) 0(1) 
N(I) 34(1) 28(1) 26(1) 1(1) 0(1) -1(1) 
C(I) 23(1) 27(1) 24(1) 3(1) 1(1) 5(1) 
C(2) 29(1) 25(1) 29(1) -2(1) -1(1) 0(1) 
C(3) 33(1) 27(1) 26(1) -5(1) -4(1) 3(1) 
N(2) 33(1) 31(1) 17(1) 0(1) 1(1) 1(1) 
C(4) 25(1) 26(1) 22(1) 0(1) 1(1) 4(1) 
0(2) 38(1) 29(1) 24(1) 1(1) 5(1) -3(1) 
C(5) 23(1) 25(1) 20(1) 1(1) 1(1) 4(1) 
C(6) 25(1) 29(1) 22(1) 3(1) 2(1) 4(1) 
C(7) 39(1) 36(1) 22(1) -3(1) 0(1) -1(1) 
146 
Table 5. Hydrogen coordinates (x 10') and isotropic displacement parameters (A2x 10 3) 
for 73. 
x y z U(eq) 
H(2) 3346 12934 3255 33 
H(3) 2504 12342 4784 34 
H(IN) 1020(30) 10864(16) 4958(17) 40 
H(7A) -324 9501 737 48 
H(7B) -487 9089 1847 48 
H(7C) 1279 8869 1222 48 
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Table 6. Torsion angles [') for 73. 
C(6)·0(1)·N(I)·C(1 ) 
0(1)·N(1)·C(I)·C(5) 
0(1)·N(I)·C(l)·C(2) 
N(I)·C(I)·C(2)·C(3) 
C(5}-C(I)·C(2}-C(3) 
C(1}-C(2}-C(3)·N(2) 
C(2}-C(3)·N(2)-C(4) 
C(3)·N(2)·C( 4}-0(2) 
C(3)·N(2)·C(4)·C(5) 
N(I)·C(I)·C(5)·C(6) 
C(2)-C(I}-C(5)-C(6) 
N(I)·C(I)·C(5}-C(4) 
C(2}-C(I)-C(5}-C( 4) 
0(2)·C( 4)·C(5)·C(6) 
N(2)·C( 4)·C( 5)·C( 6) 
0(2)-C( 4)·<:;(5)·C(I) 
N(2)-C(4)·C(5)·C(1 ) 
N(I)·0(1)·C(6)·C(5) 
N(I)·0(1)·C(6)·C(7) 
C(I )·C(5)-C( 6)·0( 1) 
C(4}-C(5)-C(6)-0(1 ) 
C(1 )·C( 5)·C( 6)·C(7) 
C( 4 )-C( 5)-C( 6)·C(7) 
Symmetry transformations used to generate equivalent atoms: 
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·0.07(17) 
·0.22(18) 
179.40(16) 
177.58(17) 
.2.8(2) 
1.4(3) 
..Q.l(3) 
·179.73(16) 
0.1(2) 
0.4(2) 
·179.23(15) 
.177.30(15) 
3.0(2) 
1.2(3) 
.178.64(17) 
178.23(16) 
·1.6(2) 
0.34(18) 
·178.88(14) 
·0.45(19) 
176.97(17) 
178.61(18) 
-4.0(3) 
Table 7. Hydrogen bonds for 73 [A and 0]. 
D·H .. .A d(D·H) d(H .. .A) 
N(2)-H(IN) ... O(2)# 1 0.88(2) 1.98(2) 
Symmetry transformations used to generate equivalent atoms: 
#1 -x,-y+2,-z+1 
149 
d(D .. .A) <(DHA) 
2.848(2) 171(2) 
C11 
Data were collected at 150(2) K on a Bruker SMART 1000 diffractometer. The structure was 
solved by direct methods and refined by full-matrix least-squares on P using the SHELXTL 
suite of programs l . All the non-hydrogen atoms were refined with anisotropic atomic 
displacement parameters, and the hydrogen atoms bonded to carbon or nitrogen were inserted 
at calculated positions uSing a riding model. The hydrogen atom bonded to oxygen was 
located from a difference map and not further refined. The saturated part of the chain showed 
some disorder, modeled as a 70:30 occupancy of two related sites for CS and 03. Details of 
the data collection and structure refinement are given in Table I. 
The carbonyl oxygen (0 I) is linked via H-bonding to two neighbouring molecules. As a 
result, the molecules are packed in paired, H-bonded columns nmning parallel to the a axis. 
I. Sheldrick a.M. (2001). SHELXTL version 6.12, Bruker AXS, Madison, Wisconsin, USA. 
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Table 1. Crystal data and structure refinement for 110. 
Identification code 11 0 
Empirical formula 
Formula weight 
Temperature 
Wavelength 
Crystal system 
Space group 
Unit cell dimensions 
Volume 
Z 
Density (calculated) 
Absorption coefficient 
F(OOO) 
Crystal size 
Crystal description 
Theta range for data collection 
Index ranges 
Reflections collected 
Independent reflections 
Completeness to theta = 25.99° 
Absorption correction 
Refinement method 
Data I restraints I parameters 
Goodness-of-fit on F2 
Final R indices [1>2sigma(l)) 
R indices (all data) 
Largest ditTo peak and hole 
CII H12N203 
220.23 
150(2) K 
0.71073 A 
Triclinic 
P-I 
a = 4.8136(7) A 
b = 8.7111(12) A 
c = 13.0695(18) A 
523.73(13) A' 
2 
1.396 Mglm' 
0.103 mm" 
232 
031 x 0.30 x 0.13 mm' 
Colourless block 
1.63\025.99°. 
c>= 72.911(2)°. 
(;>= 89.207(2)°. 
.... = 89.023(2)°. 
-5<=h<=5, -I O<=k<= 10, -16<=1<= 16 
4065 
2040 [R(int) = 0.0341] 
99.4% 
None 
Full-matrix least-squares on F2 
2040/01164 
1.055 
RI = 0.0441, wR2 = 0.1133 
RI = 0.0568, wR2 = 0.1222 
0.280 and -0.336 eA' 
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Table 2. Atomic coordinates (x 10") and equivalent isotropic displacement parameters (A'x 10') 
for 110. V(eq) is defined as one third of the trace of the orthogonalized Vij tensor. 
x y z U(eq) 
C(I) 1997(3) 10878(2) 5842(\) 23(\) 
0(1) 3590(2) 9748(1) 6300(\) 28(1) 
N(I) 2228(3) 116i8(2) 4775(1) 25(1) 
C(2) 583(4) 12897(2) 4193(\) 26(1) 
C(3) -1502(4) 13534(2) 4639(1) 26(1) 
C(4) -1947(3) 12823(2) 5766(1) 24(1) 
N(2) -3869(3) 13221(2) 6374(1) 29(1) 
0(2) -3390(3) 12126(2) 7413(1) 31(1) 
C(5) -1233(4) 1\136(2) 7377(1) 27(1) 
C(6) -236(3) 11519(2) 6354(1) 22(1) 
C(7) -482(4) 9915(2) 8396(2) 36(1) 
C(8) -2665(8) 8586(4) 8810(2) 29(1) 
0(3) -3508(6) 7857(3) 8030(2) 38(1) 
C(9) -\367(6) 7299(3) 9736(2) 49(1) 
C(7') -482(4) 9915(2) 8396(2) 36(1) 
C(8? -1432(17) 8356(9) 8537(6) 31(2) 
0(3') -4395(13) 8269(9) 8422(5) 50(2) 
C(9') -1367(6) 7299(3) 9736(2) 49(1) 
C(IO) -2746(5) 6814(3) 10635(2) 57(1) 
C(II) -1761(5) 56\3(3) 11631(2) 48(1) 
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Table 3. Bond lengths [A] and angles [0] for 110. 
C(I)-O(I) 1.247(2) O(2)-C(S) 1.348(2) 
C(l)-N(I) 1.3S8(2) C(S)-C(6) 1.362(3) 
C(1)-C(6) 1.447(2) C(S)-C(7) 1.48S(3) 
N(I)-C(2) 1.391(2) C(7)-C(S) I.S47(4) 
C(2)-C(3) 1.34S(2) C(8)-O(3) 1.417(4) 
C(3)-C(4) 1.434(2) C(S)-C(9) I.S20(4) 
C(4)-N(2) 1.318(2) C(9)-C(1O) 1.302(4) 
C(4)-C(6) 1.426(2) C(S')-O(3') 1.442(10) 
N(2)-O(2) 1.430S(19) C( IO)-C( 11) 1.4S7(3) 
O(l)-C(I)-N(1) 121.10(16) O(2)-C(S)-C(7) 116.SI(16) 
O(I)-C(I)-C(6) 12S.43(16) C( 6)-C( S)-C(7) 134.54(17) 
N(I)-C(1)-C(6) 113.47(14) C(S)-C(6)-C(4) IOS.0S(16) 
C(1)-N(I)-C(2) 1 2S.S2(1 S) C(S)-C(6)-C(I) 133.41(16) 
C(3)-C(2)-N(1) 122.83(16) C(4)-C(6)-C(1) 12I.S4(16) 
C(2)-C(3)-C(4) 116.16(1S) C(S)-C(7)-C(S) 114.30(19) 
N(2)-C(4)-C(6) 112.19(16) O(3)-C(S)-C(9) 108.4(2) 
N(2)-C(4)-C(3) 127.34(16) O(3)-C(8)-C(7) 113.S(3) 
C(6)-C(4)-C(3) 120.46(16) C(9)-C(8)-C(7) 107.3(3) 
C(4)-N(2)-O(2) 103.90(13) C(10)-C(9)-C(S) I1S.7(3) 
C(S)-O(2)-N(2) 110.21(13) C(9)-C(10)-C(11) 126.0(2) 
O(2)-C(S)-C(6) IOS.6S(lS) 
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Table 4. Anisotropic displacement parameters (A'x 10') for liD. The anisotropic 
displacement factor exponent takes the form: -2A'[ h' a''V" + ... + 2 h k a' bO V12 J 
V" 0" U" V" U13 V12 
C(I) 22(1) 20(1) 27(1) -6(1) -5(1) -2(1) 
0(1) 26(1) 26(1) 29(1) -6(1) -5(1) 6(1) 
N(1) 22(1) 25(1) 26(1) -7(1) 0(1) 3(1) 
C(2) 29(1) 24(1) 22(1) -2(1) -2(1) 0(1) 
C(3) 27(1) 21(1) 27(1) -3(1) -4(1) 1(1) 
C(4) 22(1) 19(1) 29(1) -6(1) -2(1) -1(1) 
N(2) 30(1) 26(1) 28(1) -3(1) 1(1) 3(1) 
0(2) 30(1) 36(1) 27(1) -6(1) 3(1) 3(1) 
C(5) 22(1) 28(1) 29(1) -6(1) -2(1) -2(1) 
C(6) 21(1) 19(1) 25(1) -3(1) -4(1) -2(1) 
C(7) 30(1) 44(1) 26(1) 1(1) -3(1) -2(1) 
C(8) 29(2) 31(2) 24(2) -5(1) -2(2) 1(1) 
0(3) 52(2) 30(1) 31(1) -5(1) -15(1) 4(1) 
C(9) 83(2) 31(1) 33(1) -6(1) -23(1) 5(1) 
C(7') 30(1) 44(1) 26(1) 1(1) -3(1) -2(1) 
C(8~ 20(4) 37(4) 28(4) 0(3) -2(3) 1(3) 
0(3~ 33(4) 61(5) 37(4) 16(3) -15(3) -12(3) 
C(9~ 83(2) 31(1) 33(1) -6(1) -23(1) 5(1) 
C(IO) 52(1) 44(1) 56(2) 13(1) -15(1) -4(1) 
C(ll) 68(2) 38(1) 32(1) -1(1) -5(1) 4(1) 
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Table 5. Hydrogen coordinates ( x 10') and isotropic displacement parameters (A'x 10 3) 
for 110. 
x y z U(eq) 
H(I) 3529 11259 4421 29 
H(2) 948 13340 3449 31 
H(3) -2615 14404 4232 31 
H(7A) -208 10464 8950 43 
H(7B) 1311 9404 8293 43 
H(8) -4334 9054 9079 34 
H(IO) -4580 8682 7492 40 
H(9) 414 6857 9660 59 
H(7'1) 1569 9866 8450 43 
H(7'2) -1211 10288 8995 43 
H(8') -398 7822 8063 37 
H(9,) 423 6807 9857 59 
H(IO) -4546 7268 10657 68 
H(l1A) 171 5309 11532 72 
H(l1B) -2927 4659 11789 72 
H(l1C) -1879 6080 12227 72 
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Table 6. Torsion angles [0] for 110. 
O(l)-C(I)-N(I)-C(2) -179.18(15) 
C(6)-C(l)-N(I)-C(2) 1.5(2) 
C(1)-N(I)-C(2)-C(3) -1.2(3) 
N(I)-C(2)-C(3)-C(4) 0.3(2) 
C(2)-C(3)-C(4)-N(2) -179.03(17) 
C(2)-C(3)-C( 4)-C( 6) 0.0(2) 
C(6)-C(4)-N(2)-O(2) 0.15(18) 
C(3)-C(4)-N(2)-O(2) 179.28(16) 
C(4)-N(2)-O(2)-C(5) -0.06(18) 
N(2)-O(2)-C(5)-C(6) -0.05(19) 
N(2)-O(2)-C(5)-C(7) -179.61(14) 
0(2)-C(5)-C(6)-C(4) 0.13(19) 
C(7)-C(5)-C(6)-C( 4) 179.59(19) 
O(2)-C(5)-C( 6)-C( I) -179.57(17) 
C(7)-C(5)-C(6)-C(1) -0.1(4) 
N(2)-C(4)-C(6)-C(5) -0.2(2) 
C(3)-C( 4 )-C(6)-C( 5) -179.38(16) 
N(2)-C(4)-C(6)-C(I) 179.57(15) 
C(3)-C( 4 )-C( 6)-C(I) 0.4(2) 
O(I)-C(I)-C(6)-C(5) 
-0.7(3) 
N(I)-C(I)-C(6)-C(5) 178.59(18) 
O(I)-C(I)-C(6)-C(4) 179.64(15) 
N( 1 )-C(I )-C( 6)-C( 4) 
-1.1(2) 
0(2)-C(5)-C(7)-C(8) 68.4(3) 
C(6)-C(5)-C(7)-C(8) -111.0(3) 
C(5)-C(7)-C(8)-O(3) 50.4(3) 
C(5)-C(7)-C(8)-C(9) 170.3(2) 
O(3)-C(8)-C(9)-C( 1 0) 
-107.5(3) 
C(7)-C(8)-C(9)-C(IO) 129.2(3) 
C(8)-C(9)-C(10)-C(II) 
-177.7(2) 
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Table 7. Hydrogen bonds for 110 [A and 0). 
D-H. .. A 
N(I)-H(I) ... O(l)#1 
O(3)-H(IO) ... O(I)#2 
d(D-H) 
0.88 
0.99 
d(H ... A) 
2.00 
1.80 
Symmetry transformations used to generate equivalent atoms: 
#1 -x+I,-y+2,-z+l #2 x-I,y,z 
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d(D ... A) 
2.8745(19) 
2.756(3) 
«DHA) 
175.0 
162.9 
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r I 
r I 
r I 
r I 
r I 
r I 
rl 
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